<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName A++V2.4.dtd?>
  <?SourceDTD.Version 2.4?>
  <?ConverterInfo.XSLTName springer2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Amino Acids</journal-id>
      <journal-title-group>
        <journal-title>Amino Acids</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0939-4451</issn>
      <issn pub-type="epub">1438-2199</issn>
      <publisher>
        <publisher-name>Springer Vienna</publisher-name>
        <publisher-loc>Vienna</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3080659</article-id>
      <article-id pub-id-type="pmid">21448658</article-id>
      <article-id pub-id-type="publisher-id">877</article-id>
      <article-id pub-id-type="doi">10.1007/s00726-011-0877-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Invited Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The creatine kinase system and pleiotropic effects of creatine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Wallimann</surname>
            <given-names>Theo</given-names>
          </name>
          <address>
            <phone>+41-44-7407047</phone>
            <fax>+41-44-7413008</fax>
            <email>theo.wallimann@cell.biol.ethz.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tokarska-Schlattner</surname>
            <given-names>Malgorzata</given-names>
          </name>
          <address>
            <phone>+33-476-514671</phone>
            <fax>+33-476-514218</fax>
            <email>malgorzata.tokarska-schlattner@ujf-grenoble.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schlattner</surname>
            <given-names>Uwe</given-names>
          </name>
          <address>
            <phone>+33-476-514671</phone>
            <fax>+33-476-514218</fax>
            <email>uwe.schlattner@ujf-grenoble.fr</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Institute of Cell Biology, ETH Zurich, Zurich, Switzerland </aff>
        <aff id="Aff2"><label>2</label>INSERM U1055 and University Joseph Fourier Grenoble 1, Laboratory of Fundamental and Applied Bioenergetics, BP 53, 38041 Grenoble cedex 9, France </aff>
        <aff id="Aff3"><label>3</label>Sch&#xFC;rmattstrasse 23, 8962 Bergdietikon, AG Switzerland </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>30</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>40</volume>
      <issue>5</issue>
      <fpage>1271</fpage>
      <lpage>1296</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>7</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2011</copyright-statement>
      </permissions>
      <abstract id="Abs1">
        <p>The pleiotropic effects of creatine (Cr) are based mostly on the functions of the enzyme creatine kinase (CK) and its high-energy product phosphocreatine (PCr). Multidisciplinary studies have established molecular, cellular, organ and somatic functions of the CK/PCr system, in particular for cells and tissues with high and intermittent energy fluctuations. These studies include tissue-specific expression and subcellular localization of CK isoforms, high-resolution molecular structures and structure&#x2013;function relationships, transgenic CK abrogation and reverse genetic approaches. Three energy-related physiological principles emerge, namely that the CK/PCr systems functions as (a) an immediately available temporal energy buffer, (b) a spatial energy buffer or intracellular energy transport system (the CK/PCr energy shuttle or circuit) and (c) a metabolic regulator. The CK/PCr energy shuttle connects sites of ATP production (glycolysis and mitochondrial oxidative phosphorylation) with subcellular sites of ATP utilization (ATPases). Thus, diffusion limitations of ADP and ATP are overcome by PCr/Cr shuttling, as most clearly seen in polar cells such as spermatozoa, retina photoreceptor cells and sensory hair bundles of the inner ear. The CK/PCr system relies on the close exchange of substrates and products between CK isoforms and ATP-generating or -consuming processes. Mitochondrial CK in the mitochondrial outer compartment, for example, is tightly coupled to ATP export via adenine nucleotide transporter or carrier (ANT) and thus ATP-synthesis and respiratory chain activity, releasing PCr into the cytosol. This coupling also reduces formation of reactive oxygen species (ROS) and inhibits mitochondrial permeability transition, an early event in apoptosis. Cr itself may also act as a direct and/or indirect anti-oxidant, while PCr can interact with and protect cellular membranes. Collectively, these factors may well explain the beneficial effects of Cr supplementation. The stimulating effects of Cr for muscle and bone growth and maintenance, and especially in neuroprotection, are now recognized and the first clinical studies are underway. Novel socio-economically relevant applications of Cr supplementation are emerging, e.g. for senior people, intensive care units and dialysis patients, who are notoriously Cr-depleted. Also, Cr will likely be beneficial for the healthy development of premature infants, who after separation from the placenta depend on external Cr. Cr supplementation of pregnant and lactating women, as well as of babies and infants are likely to be of benefit for child development. Last but not least, Cr harbours a global ecological potential as an additive for animal feed, replacing meat- and fish meal for animal (poultry and swine) and fish aqua farming. This may help to alleviate human starvation and at the same time prevent over-fishing of oceans.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Creatine kinase isoforms</kwd>
        <kwd>Microcompartments</kwd>
        <kwd>Beneficial effects of creatine supplementation</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2011</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p>Creatine (Cr) has emerged as a safe nutritional supplement not only to increase muscle mass and performance, prevent disease-induced muscle atrophy and improve rehabilitation, but also to strengthen cellular energetics in general (see Salomons and Wyss 2007). The latter represents the physiological basis for the beneficial effects of Cr supplementation in the treatment of multiple pathologies that display bioenergetic dysregulation, such as myopathies or neurodegenerative diseases (see Andres et al. <xref ref-type="bibr" rid="CR8">2008</xref>). Although Cr effects are likely due to pleiotropic cellular functions, its main role is in the creatine kinase (CK/PCr) system for temporal and spatial energy buffering. Interdisciplinary approaches in the frame of a system bioenergetics have been successfully applied in the past and will further be necessary to understand the CK/PCr system in more detail (Saks et al. <xref ref-type="bibr" rid="CR155">2006a</xref>; Saks <xref ref-type="bibr" rid="CR150">2007</xref>). This review first summarizes the fundamental knowledge that has been accumulated on the complex CK/PCr system over the last three decades, and in a second part gives an overview on the pleiotropic effects of Cr related to Cr supplementation as an adjuvant therapy in various pathologies. Exciting new discoveries related to anti-oxidant and anti-apoptotic effects, as well as protection of membranes by PCr are also discussed with respect to cell protection by Cr.</p>
    </sec>
    <sec id="Sec2">
      <title>The CK/PCr system for temporal and spatial buffering and regulation of cellular energetics</title>
      <sec id="Sec3">
        <title>Creatine and creatine kinase</title>
        <p>Although ATP represents the universal energy currency in all organisms and cells, ATP levels are not simply up-regulated in cells with high and/or intermittently fluctuating energy demand. Elevation of the intracellular ATP concentration [ATP], as an immediate energy reserve, followed by its hydrolysis, would lead to a massive accumulation of ADP plus P<sub>i</sub> and also liberate H<sup>+</sup>, acidifying the cytosol. Since this would inhibit ATPases, such as the myofibrillar acto-myosin ATPase and consequently muscle contraction, and many other cellular processes, nature has evolved a means to deal with the problem of the immediate replenishment of ATP stores. The so-called phosphagens evolved as high-energy compounds that are &#x201C;metabolically inert&#x201D; and as such do not interfere with primary metabolism. One of them, PCr, together with its corresponding kinase, CK, first appeared at the dawn of eukaryotic evolution some one billion years ago (Bertin et al. <xref ref-type="bibr" rid="CR15">2007</xref>).</p>
        <p>CK catalyses the reversible reaction: <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\text{PCr}}^{2 - } + {\text{MgADP}}^{ - } {\text{ + H}}^{ + } \triangleleft - {\text{CK}} - \triangleright {\text{MgATP}}^{2 - } {\text{ + Cr}} $$\end{document}</tex-math><inline-graphic xlink:href="726_2011_877_Article_IEq1.gif"/></alternatives></inline-formula> and can thus either utilize PCr (with a higher &#x2206;G free energy change than ATP) to regenerate ATP or alternatively capture immediately available cellular energy, storing up to 10 times the amount in the ATP pool. The CK system stabilizes cellular [ATP] at approximately 3&#x2013;6&#xA0;mM, depending on the cell type, at the expense of [PCr], and thus maintains the intracellular ATP/ADP ratio at a very high level and consequently keeps the &#x2206;G free energy change of ATP hydrolysis as high as possible. This guarantees an efficient use of ATP for all types of cellular functions; that is, the energy gained per ATP hydrolysed is kept at a physiological maximum. Resynthesis of ATP by the CK reaction, for example upon activation of muscle contraction, also removes ADP and H<sup>+</sup> as products of ATP hydrolysis, so that the net product of ATPase plus the CK reaction is liberation of Pi as a metabolic signal. Thus, the CK acts not only acts as an energy buffer but also as a metabolic regulator (for review, see Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>, <xref ref-type="bibr" rid="CR226">2007</xref>).</p>
      </sec>
      <sec id="Sec4">
        <title>CK isoforms and their molecular structure</title>
        <p>CK, which is crucially involved in a plethora of bioenergetic processes, is particularly important and is expressed at high levels in cells with high energy requirements such as skeletal, cardiac and smooth muscle, kidney, brain and neuronal cells, retina photoreceptor cells, spermatozoa and sensory hair cells of the inner ear (Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>, <xref ref-type="bibr" rid="CR226">2007</xref>). The most important feature for the cellular functions of the CK/PCr system is the presence of tissue- and cell-specific CK isoforms with defined subcellular locations. All CK isoforms are encoded by separate nuclear genes and, in most tissues, a single cytosolic CK isoform is co-expressed together with a single mitochondrial CK isoform (mtCK). Cytosolic muscle-type CK (M-CK) and brain-type CK (B-CK) form homo&#x2013;dimers or hetero-dimers, e.g. MM-CK in skeletal muscle, MM-, MB- and BB-CK in heart, or BB-CK in brain, kidney, spermatozoa, skin and many other tissues. MtCK is situated in the outer mitochondrial compartment and occurs as sarcomeric mtCK (smtCK) expressed mainly in muscle tissue and as ubiquitous mtCK (umtCK) expressed in a large number of other cells and tissues. Both form homo-dimers and homo-octamers, with the latter being the predominant oligomeric form in vivo.</p>
        <p>Importantly, CK isoforms are localized differentially on a subcellular level and these specific locations are essential for the functioning of the CK network (Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>, <xref ref-type="bibr" rid="CR226">2007</xref>). As for many other cellular processes, &#x201C;location, location is the name of the game&#x201D; (Hurtley <xref ref-type="bibr" rid="CR84">2009</xref>). The proposed CK/PCr energy shuttle (Wallimann <xref ref-type="bibr" rid="CR217">1975</xref>; Saks et al. <xref ref-type="bibr" rid="CR151">1978</xref>; Bessman and Geiger <xref ref-type="bibr" rid="CR18">1981</xref>; Bessman <xref ref-type="bibr" rid="CR16">1986</xref>, <xref ref-type="bibr" rid="CR17">1987</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>, <xref ref-type="bibr" rid="CR166">b</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>) connects sites of ATP production (glycolysis and mitochondrial oxidative phosphorylation) with subcellular sites of ATP utilization (ATPases). The molecular bases for this spatial energy buffering are functionally coupled, subcellular CK micro-compartments, at sites where ATP production and ATP consumption are tightly connected to CK/PCr action. At these subcellular sites, CK reactions may run in different (forward or backward) directions, but on the global cellular or organ level the CK system appears to be as if in equilibrium (see Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>The CK/PCr system for temporal and spatial energy buffering in cells of high and fluctuating energy requirements. Cr enters the target cells via Cr transporter (CRT). Inside the cell, PCr/Cr and ATP/ADP equilibria are adjusted by a soluble fraction of cytosolic CK isoforms (CK-c, see (3)). Another fraction of cytosolic CK (CK-g, see (2)) is specifically coupled to glycolytic enzymes (G), accepting glycolytic ATP, while mitochondrial CK isoforms (mtCK, see (1)) is coupled to adenine nucleotide translocator (ANT), thus accepting ATP exported from the matrix and generated by oxidative phosphorylation (OP). The contribution of both of these so-called microcompartments to total PCr generation depends on the cell type. The PCr thus generated is fed into the large PCr pool (up to 30&#xA0;mM) that is available as a temporal or spatial energy buffer. Another fraction of cytosolic CK (CK-a, see (4)) specifically associated with subcellular sites of ATP utilization (ATPase, e.g. ATP-dependent or ATP-gated processes, ion-pumps etc.) also forms tightly coupled microcompartments regenerating the ATP utilized by the ATPase reaction in situ on the expense of PCr. The proposed CK/PCr energy shuttle or circuit connects, via highly diffusible PCr and Cr, subcellular sites of ATP production (glycolysis and mitochondrial oxidative phosphorylation) with subcellular sites of ATP utilization (ATPases). This model is based on functionally coupled, subcellular CK microcompartments, where ATP production and ATP consumption are tightly connected to CK/PCr action (Wallimann <xref ref-type="bibr" rid="CR217">1975</xref>; Wallimann and Eppenberger <xref ref-type="bibr" rid="CR219">1985</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>)</p></caption><graphic xlink:href="726_2011_877_Fig1_HTML" id="MO1"/></fig></p>
        <p>The molecular structures of CK isoforms have been solved at atomic level (Fritz-Wolf et al. <xref ref-type="bibr" rid="CR58">1996</xref>; Rao et al. <xref ref-type="bibr" rid="CR141">1998</xref>; Eder et al. <xref ref-type="bibr" rid="CR51">1999</xref>, <xref ref-type="bibr" rid="CR52">2000a</xref>; reviewed by McLeish and Kenyon <xref ref-type="bibr" rid="CR115">2005</xref>) and their biochemical characteristics, e.g. enzyme catalysis, oligomerization, membrane interaction and binding to subcellular structures (e.g. Rossi et al. <xref ref-type="bibr" rid="CR146">1990</xref>; Eder et al. <xref ref-type="bibr" rid="CR53">2000b</xref>; Hornemann et al. <xref ref-type="bibr" rid="CR79">2000</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR161">2000</xref>; Schlattner and Wallimann <xref ref-type="bibr" rid="CR160">2000</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR164">2004</xref>) and specific interaction with subcellular partners and domains involved in such interactions (Kraft et al. <xref ref-type="bibr" rid="CR101">2000</xref>; Hornemann et al. <xref ref-type="bibr" rid="CR80">2003</xref>) have been studied in detail over the past decades. These studies have revealed important aspects of structure&#x2013;function relationships and molecular physiology of CK that has allowed an understanding of the CK/PCr system and its eminent physiological role (Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>).</p>
      </sec>
      <sec id="Sec5">
        <title>Temporal and spatial energy buffering</title>
        <p>Cr derived either from endogenous synthesis in the body or taken up from alimentary sources, e.g. meat and fish, is transported into muscle and other target cells with high and fluctuating energy requirements by a specific creatine transporter (CRT) (Speer et al. <xref ref-type="bibr" rid="CR178">2004</xref>; Straumann et al. <xref ref-type="bibr" rid="CR186">2006</xref>; see Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref> with respective labels and numbering used in the following text). Imported Cr is charged to the high-energy compound PCr by the action of either strictly soluble, cytosolic CK (<bold>CK-c</bold>, (<bold>3</bold>)), by CK coupled to glycolysis (<bold>CK-g</bold>, (<bold>2</bold>)) or by mtCK coupled to oxidative phosphorylation (OP) (<bold>mtCK</bold>, (<bold>1</bold>)). In a resting cell, this results, at equilibrium, in a distribution of the total Cr pool into approximately two-thirds [PCr] and one-third [Cr] and in a very high ATP/ADP ratio (&#x2265;100:1). A fraction of cytosolic isoforms of CK are specifically associated with ATP-consuming processes (<bold>CK-a</bold>, (<bold>4</bold>)), such as the myofibrillar acto-myosin ATPase, the SR Ca<sup>2+</sup>-ATPase, the plasma membrane Na<sup>+</sup>/K<sup>+</sup>-ATPase, the ATP-gated K<sup>+</sup>-channel or ATP-requiring constituents for cell signalling.</p>
        <p>Within these functional micro-compartments, CK regenerates the utilized ATP, drawing from the large PCr pool. These micro compartments with associated CK represent the ATP/PCr-consuming side of the CK/PCr system <bold>(4)</bold>. At the ATP/PCr-generating side of the system, there are the glycogenolytic/glycolytic CK-g microcompartments (<bold>2</bold>) and the mtCK microcompartment connected to OP and energy channelling reactions inside the mitochondrion (<bold>1</bold>) (Schlattner et al. <xref ref-type="bibr" rid="CR166">2006b</xref>). MtCK is specifically located in the intermembrane space of mitochondria with preferential access to ATP generated by OP via adenine nucleotide translocator (ANT) of the mitochondrial inner membrane. This mitochondrial ATP is trans-phosphorylated into PCr that then leaves the mitochondria (Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>). This route of ATP generation is most important for refilling the PCr energy store in oxidative tissues, e.g. upon extensive stimulation of muscle contraction and thus is relevant for recovery after exhausting exercise (Quistorff et al. <xref ref-type="bibr" rid="CR139">1993</xref>).</p>
        <p>A large cytosolic PCr pool of up to 30&#xA0;mM is built up by CK using ATP predominantly from OP (<bold>1)</bold> as in the heart, or from glycolysis (<bold>2</bold>) plus OP <bold>(1)</bold> as in skeletal muscle. PCr is then used to buffer global cytosolic (<bold>3</bold>) and local (<bold>4</bold>) ATP/ADP ratios. This would represent the temporal buffer function of the system. This function has been confirmed using reverse genetic approaches. For example, by introducing a phosphagen kinase gene, the CK orthologue arginine kinase (AK), into <italic>Escherichia coli</italic> or yeast, a phospho-arginine pool was built up that improved recovery of the bacteria and yeast from transient pH stress (Canonaco et al. <xref ref-type="bibr" rid="CR30">2002</xref>, <xref ref-type="bibr" rid="CR31">2003</xref>). By a similar strategy, yeast cells into which the genes for the enzymes for Cr biosynthesis (AGAT and GAMT) plus CK were introduced, proved to be resistant to metabolic stressors, such as low pH and starvation, by stabilizing the ATP levels during the transient stress period to pre-stress levels (Canonaco et al. <xref ref-type="bibr" rid="CR30">2002</xref>).</p>
        <p>In cells that are polarized and/or have very high or localized ATP consumption (<bold>4</bold>), the differentially localized CK isoforms, together with easily diffusible PCr and Cr, maintain a high-energy PCr/Cr-circuit between ATP-providing (<bold>1, 2</bold>) and ATP-consuming processes (<bold>3, 4</bold>). Thus, the energy producing and consuming terminals of the shuttle are connected via PCr and Cr, with no obligatory need for ATP or ADP to diffuse, for example, from mitochondria (<bold>1</bold>) to the sites of ATPases (<bold>4</bold>) or backwards, respectively. Metabolite channelling (Schlattner et al. <xref ref-type="bibr" rid="CR167">2011</xref>) occurs where CK is associated with ATP-providing (<bold>1, 2</bold>) or ATP-consuming processes (<bold>4</bold>), that may be represented by ATPases, such as the actin-activated myosin MgATPase for muscle contraction (Wallimann et al. <xref ref-type="bibr" rid="CR221">1984</xref>; Ventura-Clapier et al. <xref ref-type="bibr" rid="CR214">1987</xref>; van Deursen et al. <xref ref-type="bibr" rid="CR206">1993</xref>) and actin-based cell motility (Kuiper et al. <xref ref-type="bibr" rid="CR105">2009</xref>), ATP-dependent ion-pumps and transporters, such as the SR Ca<sup>2+</sup> pump (Rossi et al. <xref ref-type="bibr" rid="CR146">1990</xref>; de Groof et al. <xref ref-type="bibr" rid="CR44">2002</xref>), the Na<sup>+</sup>/K<sup>+</sup>-ATPase (Guerrero et al. <xref ref-type="bibr" rid="CR68">1997</xref>), the gastric H<sup>+</sup>/K<sup>+</sup>-ATPase (Sistermans et al. <xref ref-type="bibr" rid="CR177">1995b</xref>), as well ATP-gated ion-channels (Dzeja and Terzic <xref ref-type="bibr" rid="CR50">1998</xref>), ATP-requiring metabolic enzymes and protein kinases, such as AMP-activated protein kinase (AMPK) (Ceddia and Sweeney <xref ref-type="bibr" rid="CR33">2004</xref>) or Akt/PKB (Deldicque et al. <xref ref-type="bibr" rid="CR45">2007</xref>, <xref ref-type="bibr" rid="CR46">2008</xref>) involved in cell signalling (Saks et al. <xref ref-type="bibr" rid="CR156">2006b</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>).</p>
      </sec>
      <sec id="Sec6">
        <title>CK in specialized polarized and epithelial cells</title>
        <p>CK is not only prominent in sarcomeric skeletal and cardiac muscle, where MM-CK is co-expressed with smtCK and where these isoforms are located at specific subcellular sites (Wegmann et al. <xref ref-type="bibr" rid="CR231">1992</xref>), but also in smooth muscle, brain and other non-muscle tissues where BB-CK is co-expressed with umtCK (Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>). For example, BB-CK is highly expressed in spermatozoa, retina photoreceptor cells (Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>) as well as in the sensory hair cells present in the inner ear (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>). The common denominator of these cells is that they are highly polar, elongated cells and that mitochondria are located at a distance from intracellular sites of ATP consumption. Therefore, these cells are the best models to investigate how mitochondrial-generated high-energy phosphates reach the sites of ATP consumption when separated by a long diffusion distance.</p>
        <sec id="Sec7">
          <title>CK in spermatozoa</title>
          <p>In sea urchin sperm, 100% of the energy required for sperm tail movement is generated in one single large mitochondrion located in the mid-piece behind the sperm head (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Mitochondria from sea urchins and other organisms harbour high concentrations of octameric mtCK (Wallimann et al. <xref ref-type="bibr" rid="CR222">1986a</xref>; Tombes and Shapiro <xref ref-type="bibr" rid="CR201">1987</xref>; Kaldis et al. <xref ref-type="bibr" rid="CR92">1996b</xref>), whereas the sperm tails contain a &#x201C;cytosolic&#x201D; CK which in sea urchins is a contiguous CK trimer (Quest et al. <xref ref-type="bibr" rid="CR138">1997</xref>), but in other organisms consists of brain-type BB-CK dimers (Wallimann et al. <xref ref-type="bibr" rid="CR222">1986a</xref>; Kaldis et al. <xref ref-type="bibr" rid="CR92">1996b</xref>). Most of the sperm tail CK is distributed along the entire sperm tail and/or associated with the cell membrane and the dynein ATPase (Quest et al. <xref ref-type="bibr" rid="CR138">1997</xref>).<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Spatial energy buffering by the CK/PCr: the PCr/Cr-shuttle in spermatozoa. Diffusion fluxes in sea urchin sperm were calculated from in vivo <sup>31</sup>P-NMR saturation transfer NMR experiments (Kaldis et al. <xref ref-type="bibr" rid="CR93">1997</xref>). The diffusion flux of ADP from the sperm tail end towards the mitochondrion located at the mid piece is more than 2,000 times slower compared with that of Cr, whereas the diffusion flux of ATP from the region of the mitochondrion towards the sperm tail is roughly seven times slower than that of PCr. Thus, the PCr/Cr-shuttle is a physiological adaptation to overcome the diffusional limitations of adenosine nucleotides, especially of ADP, to facilitate long-distance energy transport, as well as high-throughput fluxes of cellular energy. A similar system has been proposed and proved to work also in the sensory hair cells of the inner ear (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>) and in the polar photoreceptor cells of the retina (Wallimann et al. <xref ref-type="bibr" rid="CR223">1986b</xref>; Hemmer et al. <xref ref-type="bibr" rid="CR76">1993</xref>; Linton et al. <xref ref-type="bibr" rid="CR111">2010</xref>) and in the sensory hair cells of the inner ear (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>). (Figure adapted from Kaldis et al. <xref ref-type="bibr" rid="CR93">1997</xref>)</p></caption><graphic xlink:href="726_2011_877_Fig2_HTML" id="MO2"/></fig></p>
          <p>In vivo experiments examining flagellar wave bending of living sea urchin sperm, which after activation were incubated with dinitrofluorobenzene (DNFB), a specific inhibitor of CK, showed that increasing concentrations of DNFB attenuated firstly flagellar wave bending, and the amplitude of bending, at the very distal end of the sperm tail. As DNFB concentrations were increased, flagellar wave attenuation was gradually and progressively affected towards the more proximal regions and the mid-piece (Tombes et al. <xref ref-type="bibr" rid="CR202">1987</xref>). Similar results had been obtained with chicken sperm (Wallimann et al. <xref ref-type="bibr" rid="CR222">1986a</xref>). This was a first and very elegant visual demonstration showing that with progressive inhibition of CK, the diffusion distances for ATP from the mitochondrion to the very end of the sperm tail are indeed limited and that after inhibition of tail CK they are no longer compensated for by PCr/Cr diffusion.</p>
          <p>Using in vivo <sup>31</sup>P-NMR saturation transfer, high-energy phosphate concentrations as well as the rate of flux through the CK reaction were measured before and after activation of intact live sea urchin sperm in sea water (van Dorsten et al. <xref ref-type="bibr" rid="CR208">1996</xref>, <xref ref-type="bibr" rid="CR209">1997</xref>), combined with concomitant measurement of O<sub>2</sub> consumption (ATP production). Knowledge of the metabolite concentrations together with their diffusion constants then allowed the calculation of diffusion fluxes of the respective metabolites (Kaldis et al. <xref ref-type="bibr" rid="CR93">1997</xref>). As shown in Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>, PCr and Cr display a significantly higher diffusion flux compared with ATP and ADP. Most remarkably, the diffusion flux of ADP from the distal sperm tail end back to the mid-piece mitochondrion is slower by three orders of magnitude compared with Cr (Kaldis et al. <xref ref-type="bibr" rid="CR93">1997</xref>). Thus, the CK/PCr shuttle is compensating for the diffusion limitations of mainly ADP and somewhat less so of ATP.</p>
        </sec>
        <sec id="Sec8">
          <title>CK in retina photoreceptor cells</title>
          <p>Similar findings on the importance of the CK/PCr system working as a spatial buffer have recently been presented for elongated photoreceptor cells of the retina (Linton et al. <xref ref-type="bibr" rid="CR111">2010</xref>). CK isoforms are expressed in all cells of the retina, but the highest levels of CK are found in the polar photoreceptor cells (Wallimann et al. <xref ref-type="bibr" rid="CR223">1986b</xref>), where cytosolic BB-CK and umtCK are located in the inner segments and some BB-CK in the outer segments of the photoreceptor cells of certain species, e.g. in bovine rod outer segments (Wegmann et al. <xref ref-type="bibr" rid="CR230">1991</xref>; Hemmer et al. <xref ref-type="bibr" rid="CR76">1993</xref>). It was postulated that this compartmented intracellular distribution of CK isoforms could induce an energy flux carried by the CK/PCr system. It would emanate from the mitochondria clustered centrally within the photoreceptor cells and propagate in two directions, towards the synapse as well as into the outer segment towards the photoactive membrane stacks in the rod outer segments (Wallimann et al. <xref ref-type="bibr" rid="CR223">1986b</xref>).</p>
          <p>Most recently, it has been shown by biochemical and electrophysiological measurements that the CK/PCr system is indeed fundamental to energy distribution in photoreceptors. In darkness, PCr emanating from the central mitochondria of the photoreceptor cells flows into the synaptic terminal, where the ATP required for sustained glutamate release (dark current) is regenerated by cytosolic CK that is localized at this shuttle terminal (Linton et al. <xref ref-type="bibr" rid="CR111">2010</xref>). Since we found BB-CK, albeit at lower levels, also in the bovine rod outer segments (Hemmer et al. <xref ref-type="bibr" rid="CR76">1993</xref>), it is conceivable that such a vectorial PCr energy transport not only runs in one direction towards the synaptic terminal, but also in the opposite direction into the rod outer segments. There, bound CK would convert PCr into ATP used for photoreceptor signalling, that is, for stabilizing the [ATP] needed for resynthesis of cGMP from GTP upon photic stimulation (Hemmer et al. <xref ref-type="bibr" rid="CR76">1993</xref>).</p>
          <p>Cr supply to the retina is important and seems to be supported by a dual system: (a) by uptake from the circulation via CRT expressed in the endothelial cells of the blood/retinal barrier, and (b) by endogenous Cr synthesis in the M&#xFC;ller glia cells (Tachikawa et al. <xref ref-type="bibr" rid="CR191">2007</xref>). Chorioretinal degeneration in patients with gyrate atrophy, who present with a Cr-deficiency syndrome, can be ascribed both to a reduced Cr supply from circulating blood and a disrupted endogenous Cr supply to the retina from the local M&#xFC;ller glia due to inhibition of Cr biosynthesis by hyper-ornithinemia (Sipila <xref ref-type="bibr" rid="CR175">1980</xref>). This indicates that the CK/PCr system is physiologically important for vision, even though up to date no phenotype for visual defects has been reported in transgenic CK knockout mice (see below).</p>
        </sec>
        <sec id="Sec9">
          <title>CK in hair cells of the inner ear</title>
          <p>Brain-type cytosolic BB-CK has been also localized in the inner ear hair cells (Spicer and Schulte <xref ref-type="bibr" rid="CR180">1992</xref>). CK was identified, by a proteomic approach with isolated hair cells from purified vestibular bundles, as the second most prominent protein besides actin, and other proteins of the cytoskeleton and proteins involved in Ca<sup>2+</sup> homeostasis, stress response and glycolysis (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>). Present at a high concentration of approximately 0.5&#xA0;mM inside the sensory hair cells, the CK enzyme is capable of maintaining constant ATP levels despite a turnover of 1&#xA0;mM ATP/s. This turnover is imposed by the plasma membrane Ca<sup>2+</sup>-ATPase pump that maintains Ca<sup>2+</sup>-cycling during activation of these specialized sensory cells. The polarized hair bundle cells cannot rely on ATP diffusion and it was shown that the CK/PCr shuttle is essential for high-sensitivity hearing and vestibular function, e.g. body balance and equilibrium. CK knockout mice presented with hearing loss and a strong vestibular phenotype (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>). Interesting in this context is the fact that Cr supplementation of healthy wild-type mice significantly attenuates noise-induced destruction of inner and more so of outer hair cells and the concomitant hearing loss (Minami et al. <xref ref-type="bibr" rid="CR123">2007</xref>). These data indicate that the maintenance of ATP levels by the CK/PCr system, possibly together with anti-oxidant properties of Cr, are important for attenuating temporary and permanent noise-induced hearing loss. Thus, Cr supplementation may be recommended as a preventive measure in professionally noise-exposed individuals.</p>
        </sec>
        <sec id="Sec10">
          <title>CK in epithelial cells</title>
          <p>Rather surprisingly, high concentrations of CK isoforms were also found in a variety of epithelial cells that are not known to have high fluctuating energy requirements, but may need energetic support for maintaining high rates of cell divisions, resorption or secretion activities. In stomach epithelium parietal cells, the CK/PCr system appears to work in conjunction with the H<sup>+</sup>/K<sup>+</sup>-ATPase pump and is involved in gastric acid secretion (Sistermans et al. <xref ref-type="bibr" rid="CR177">1995b</xref>). In epithelial cells of the intestine (Sistermans et al. <xref ref-type="bibr" rid="CR176">1995a</xref>) CK may be involved in food absorption and transport, as well as cell renewal. In skin, BB-CK and umtCK have been localized in the keratinocytes of the highly proliferative suprabasal layer of the epidermis, as well as in the hair follicles and sebaceous glands (Schlattner et al. <xref ref-type="bibr" rid="CR163">2002</xref>), indicating a function of the CK/PCr system for normal skin function (Zemtsov <xref ref-type="bibr" rid="CR237">2007</xref>), proliferation and hair growth (Schlattner et al. <xref ref-type="bibr" rid="CR163">2002</xref>). During wound healing, CK isoforms were highly upregulated indicating a function of CK and Cr (Schlattner et al. <xref ref-type="bibr" rid="CR163">2002</xref>). In accordance with the postulated important functions of the CK system in skin, topical application of a Cr containing lotion directly onto skin has been shown to exert a marked protection from UV-induced oxidative damage and mutagenesis in vitro (Berneburg et al. <xref ref-type="bibr" rid="CR14">2005</xref>) and in vivo (Lenz et al. <xref ref-type="bibr" rid="CR109">2005</xref>).</p>
          <p>There is still a widely expressed concern that Cr supplementation may be deleterious to the kidney. This, unfortunately, has to do with the fact that creatine (Cr) is still mixed-up with creatinine (Crn). Crn is the cyclic degradation product of Cr that is generated by non-enzymatic conversion from Cr, until a roughly 2/3&#x2013;1/3 chemical equilibrium between Crn and Cr is established. Crn content is measured as a kidney function marker in the serum of patients because it is very prominent and easy to measure chemically. While an accumulation of Crn in the serum normally indicates that kidney function is impaired, this is entirely unrelated to the somewhat higher serum Cr and/or Crn concentrations during Cr supplementation which, in this case, is not indicative of kidney malfunction or any general toxicity. As the Crn concentration may increase somewhat with Cr supplementation (Schedel et al. <xref ref-type="bibr" rid="CR159">1999</xref>), due to the chemical equilibrium reaction between Cr and Crn, this is often taken as a false argument for impairment of kidney function, but in fact is a normal consequence of Cr intake. On the contrary, CK and Cr are important for kidney function. CK is highly expressed in kidney epithelial cells (Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>) and the CK/PCr system supports Na<sup>+</sup>/K<sup>+</sup>-ATPase ion pump function in the kidney (Guerrero et al. <xref ref-type="bibr" rid="CR68">1997</xref>). In addition, kidney proximal tubule epithelial cells also express Cr transporter (CRT) that is responsible for resorption and salvaging of Cr, a valuable guanidino compound, from the urine (Li et al. <xref ref-type="bibr" rid="CR110">2010</xref>). So, one may argue that if Cr would be deleterious for the kidney, why would the kidney absorb Cr from the urine instead of secreting it? Indeed, in a placebo-controlled double-blind clinical study, involving healthy men, Cr supplementation at 10&#xA0;g/day for 3&#xA0;months had no deleterious effect on kidney function (Gualano et al. <xref ref-type="bibr" rid="CR66">2008b</xref>). In a single case study concerning a man with only one kidney, who presented with a mildly decreased glomerular filtration rate, no Cr-induced deleterious effects of Cr supplementation (20&#xA0;g/day for 30 days) were observed (Gualano et al. <xref ref-type="bibr" rid="CR67">2010</xref>). Even long-term Cr supplementation (4&#xA0;g/day for 2&#xA0;years) is today considered safe, as seen in aged Parkinson patients (Bender et al. <xref ref-type="bibr" rid="CR13">2008b</xref>). Thus, Cr taken at the recommended dosage in a chemically pure form is not deleterious to kidney function and health.</p>
        </sec>
      </sec>
      <sec id="Sec11">
        <title>Functions of cytosolic CK associated with glycolysis</title>
        <p>A fraction of cytosolic CK is associated with the glycolytic enzyme complex (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, (<bold>2</bold>)) that, in sarcomeric muscle, is concentrated at the myofibrillar I-band (Kraft et al. <xref ref-type="bibr" rid="CR101">2000</xref>). It was shown that there, CK is specifically associated with those glycolytic enzymes that are either involved in ATP generation, such as pyruvate kinase (PK) (Dillon and Clark <xref ref-type="bibr" rid="CR48">1990</xref>; Kraft et al. <xref ref-type="bibr" rid="CR101">2000</xref>) or with the main regulatory enzyme of glycolysis, phosphofructokinase (PFK), which is regulated by rising [ATP] via a negative feed-back mechanism of ATP on PFK (Kraft et al. <xref ref-type="bibr" rid="CR101">2000</xref>). The CK-PFK interaction is pH-dependent and stronger at lower pH than at neutrality. This is physiologically relevant since under conditions of muscle activation and working glycolysis, the intracellular pH may drop. Thus, if glycolysis is initiated immediately after contraction to produce ATP, the close structural and functional association of CK with distinct members of the glycolytic micro-compartment makes sense in two ways: (a) glycolytic ATP is immediately removed from this compartment by associated CK and thus inhibition of glycolysis by negative feed-back regulation via ATP accumulation is prevented, and (b) glycolytic ATP can be used concomitantly to reduce the depletion of the PCr pool during contraction (Kraft et al. <xref ref-type="bibr" rid="CR101">2000</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>). The principle of tight functional coupling of glycolysis to CK action has been shown in vitro in a system of reconstituted glycolysis containing CK (Scopes <xref ref-type="bibr" rid="CR170">1973</xref>) and also in vivo in an anoxic goldfish model (van den Thillart et al. <xref ref-type="bibr" rid="CR205">1989</xref>) where mitochondrial function is basically eliminated due to lack of oxygen. There, clearly, glycolytic ATP was shown to be used to replenish the PCr pool, although not to the maximal extent (van den Thillart et al. <xref ref-type="bibr" rid="CR205">1989</xref>; Van Waarde et al. <xref ref-type="bibr" rid="CR211">1990</xref>).</p>
        <p>The coupling of CK to the glycogenolytic/glycolytic pathway is also supported by gated <sup>31</sup>P-NMR measurements following at very high time-resolution the metabolite fluctuations elicited by single muscle contractions (Chung et al. <xref ref-type="bibr" rid="CR37">1998</xref>). After a single contraction the recovery of PCr is much faster than at the end of stimulation. This implies a distinct recovery mechanism in the first phase, which is in line with the contention that a significant proportion of glycogenolytic/glycolytic ATP is immediately used and trans-phosphorylated by CK to replenish PCr (see also Shulman <xref ref-type="bibr" rid="CR174">2005</xref>). After the end of stimulation, however, PCr recovery kinetics is consistent with a predominant role of OP (van den Thillart et al. <xref ref-type="bibr" rid="CR205">1989</xref>; Van Waarde et al. <xref ref-type="bibr" rid="CR211">1990</xref>; Quistorff et al. <xref ref-type="bibr" rid="CR139">1993</xref>; Chung et al. <xref ref-type="bibr" rid="CR37">1998</xref>). Finally, transgenic CK knock-out mice show an altered glycolytic network in their CK-deficient muscles (de Groof et al. <xref ref-type="bibr" rid="CR42">2001a</xref>), which also indicates an intricate interconnection of the two systems. This is corroborated by the fact that muscles of PFK-deficient patients show a dramatic delay in PCr recovery following exercise (Grehl et al. <xref ref-type="bibr" rid="CR64">1998</xref>).</p>
      </sec>
      <sec id="Sec12">
        <title>Functions of mitochondrial CK (mtCK)</title>
        <sec id="Sec13">
          <title>Metabolite channelling in the mtCK microcompartment</title>
          <p>After the import of nuclear encoded, nascent mtCK through the mitochondrial outer membrane and cleavage of the N-terminal targeting sequence, mtCK first assembles into dimers. These dimers rapidly associate into octamers and although this reaction is reversible, octamer formation is strongly favoured by the high mtCK concentration in the inter-membrane space (Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>). The symmetrical and cube-like mtCK octamers (Fritz-Wolf et al. <xref ref-type="bibr" rid="CR58">1996</xref>; Eder et al. <xref ref-type="bibr" rid="CR52">2000a</xref>) then directly bind to acidic phospholipids in the mitochondrial membranes (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>), preferentially to cardiolipin of the inner mitochondrial membrane (Schlattner et al. <xref ref-type="bibr" rid="CR164">2004</xref>), and in a calcium-dependent manner directly to VDAC (Schlattner et al. <xref ref-type="bibr" rid="CR162">2001</xref>). Affinity of both ANT and mtCK for cardiolipin situates them in common cardiolipin patches (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>), which can also be induced by membrane-bound mtCK (Epand et al. <xref ref-type="bibr" rid="CR55">2007b</xref>), thus allowing for a functional interaction between both proteins (Wallimann et al. <xref ref-type="bibr" rid="CR225">1998</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR166">2006b</xref>). MtCK is found in two locations (Wegmann et al. <xref ref-type="bibr" rid="CR230">1991</xref>): (a) in the so-called mitochondrial contact sites (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>), where mtCK simultaneously binds to inner and outer membrane due to its symmetrical octameric structure (see below) and where it functionally associates with ANT and VDAC (Kottke et al. <xref ref-type="bibr" rid="CR99">1991</xref>) and (b) in the cristae (not shown) associated with inner membrane and ANT only (Wegmann et al. <xref ref-type="bibr" rid="CR230">1991</xref>; for details, see Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>, <xref ref-type="bibr" rid="CR167">2011</xref>). A well-coupled MtCK micro compartment is also maintained by diffusion restrictions for adenylates at the outer membrane VDAC, possibly via direct interaction of VDAC with tubulin (Rostovtseva et al. <xref ref-type="bibr" rid="CR147">2008</xref>). The preferred or exclusive substrate and product fluxes in a well-coupled mtCK microcompartment are indicated in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref> by black arrows (Saks et al. <xref ref-type="bibr" rid="CR154">2000</xref>); minor or alternative fluxes at a lower degree of coupling are shown with blue arrows.<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Mitochondrial mtCK functions for high-energy metabolite channelling in mitochondria. In cells with oxidative metabolism, respiration (green arrow), ATP synthesis and ATP export through the inner mitochondrial membrane via adenine nucleotide transporter (ANT) are tightly coupled to trans-phosphorylation of ATP to PCr by mtCK and export of PCr into the cytosol by the outer membrane voltage-dependent anion channel (VDAC) as indicated by black arrows. In turn, Cr stimulates respiration by favoring constant supply of ADP to the matrix (black arrows), which also lowers ROS/RNS production in the intra-mitochondrial space (red arrows) and inhibits mitochondrial permeability transition. The tight coupling of substrate and product fluxes (black arrows) allows a so-called channeling of &#x201C;high-energy&#x201D; metabolites, with PCr being the one released into the cytosol, and ATP/ADP being mainly recycled within the mitochondria. The structural basis of these mtCK microcompartments are proteolipid complexes containing either VDAC, octameric mtCK and ANT in the peripheral intermembrane space (as shown) or octameric mtCK and ANT in the cristae (not shown). These proteolipid complexes are maintained by mtCK interactions with anionic phospholipids and VDAC in the outer membrane, and with cardiolipin and thus indirectly with cardiolipin-associated ANT in the inner membrane (see cardiolipoin patches). In cases of a less coupled mtCK microcompartment, e.g. after impairment of mtCK function by oxidative damage, there is partial direct ATP/ADP exchange with the cytosol (blue arrows). (Figure adapted from Kaldis et al. <xref ref-type="bibr" rid="CR93">1997</xref>; Meyer et al. <xref ref-type="bibr" rid="CR120">2006</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR167">2011</xref>) (The different fluxes are indicated by <italic>coloured arrows</italic> in the figure)</p></caption><graphic xlink:href="726_2011_877_Fig3_HTML" id="MO3"/></fig></p>
          <p>According to this scheme, ATP generated by OP via the F<sub>0</sub>F<sub>1</sub>-ATPase is transported through the inner membrane by ANT in exchange for ADP. This ATP may either leave the mitochondrion directly via outer membrane VDAC or is preferentially accepted and trans-phosphorylated into PCr by octameric mtCK in the intermembrane space. PCr then preferentially leaves the mitochondrion via VDAC and feeds into the large cytosolic PCr pool. ADP generated from the mtCK trans-phosphorylation reaction is accepted by ANT and immediately transported back into the matrix to be recharged. In contact sites, this substrate channelling allows for a constant supply of substrates and removal of products at the active sites of mtCK. In cristae, only ATP/ADP exchange is facilitated through direct channelling to the mtCK active site, while Cr and PCr have to diffuse along the cristae space to reach VDAC (not shown; for details, see Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>, <xref ref-type="bibr" rid="CR166">b</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>).</p>
          <p>Functional coupling of ANT to mtCK leads to a saturation of mtCK with ANT-delivered ATP, and at the same time to a locally high ATP/ADP ratio in the vicinity of mtCK. In combination with cytosolic Cr, entering the intermembrane space via VDAC, these conditions are favourable to drive the synthesis of PCr from ATP by mtCK without loss of energy content. This maintains maximal thermodynamic efficiency for high-energy phosphate synthesis and channelling, which in the form of PCr is exported into the cytosol (Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>). Such a reaction sequence represents an instructive example of functional coupling and metabolite channelling. The active ATP/ADP exchange maintained by coupled mtCK favours ATP generation by the F<sub>0</sub>F<sub>1</sub>-ATPases and thus proper functioning of the respiratory chain, which could otherwise generate elevated levels of superoxide and reactive oxygen species (ROS) (Schlattner et al. <xref ref-type="bibr" rid="CR167">2011</xref>).</p>
          <p>The intricate functional coupling of mtCK to the ANT (Vendelin et al. <xref ref-type="bibr" rid="CR213">2004</xref>), leading to a saturation of the ANT on the outer site of the inner membrane with ADP, which then is transported back into the matrix to be recharged by the F<sub>0</sub>F<sub>1</sub>-ATPase, efficiently couples substrate oxidation to ATP generation. Such tight coupling, by avoiding futile electron transfer, conceivably also would lower the production of free oxygen radicals (ROS). Indeed, mitochondrial respiration in the presence of Cr needs only micromolar concentrations of ADP to be fully stimulated, whereas in the absence of Cr comparably high concentration of ADP in the millimolar range are needed for a similar respiratory rate (Kay et al. <xref ref-type="bibr" rid="CR95">2000</xref>; Saks et al. <xref ref-type="bibr" rid="CR154">2000</xref>). This important phenomenon, termed &#x201C;creatine-stimulated respiration&#x201D; is entirely dependent on the presence of mtCK, for mitochondrial respiration can no longer be stimulated by Cr in intact chemically skinned muscle fibres or mitochondria isolated from cardiac or skeletal muscle of smtCK knockout mice (Kay et al. <xref ref-type="bibr" rid="CR95">2000</xref>). Finally, Cr exerts a strong indirect anti-oxidant effect by significantly reducing the intra-mitochondrial production of ROS, as well as elevating and preserving the mitochondrial membrane potential (Meyer et al. <xref ref-type="bibr" rid="CR120">2006</xref>). These Cr-meditated events may represent the basis for some of the remarkable neuro-protective effects of Cr that had been discovered recently (reviewed by Andres et al. <xref ref-type="bibr" rid="CR8">2008</xref>).</p>
        </sec>
        <sec id="Sec14">
          <title>MtCK and mitochondrial membranes</title>
          <p>Both, sarcomeric smtCK (Fritz-Wolf et al. <xref ref-type="bibr" rid="CR58">1996</xref>) and ubiquitous umtCK (Eder et al. <xref ref-type="bibr" rid="CR52">2000a</xref>) show cube-like octameric structures of mtCK with approximately 100 &#xC5; side lengths, built by four identical mtCK dimers that are arranged by fourfold symmetry around a central channel of approximately 20 &#xC5; in diameter. These octamers maintain multiple and complex interactions with the phospholipids of the mitochondrial membranes (reviewed by Schlattner et al. <xref ref-type="bibr" rid="CR166">2006b</xref>). By their identical top and bottom faces, which each expose four C-termini, MtCK binds strongly to anionic phospholipids, in particular cardiolipin that is abundant in the inner mitochondrial membrane. By virtue of their molecular symmetry, mtCKs are also able to cross-link two membranes. Both membrane-binding and cross-linking characteristics of mtCK have been thoroughly investigated and quantified by a number of biophysical techniques (Rojo et al. <xref ref-type="bibr" rid="CR145">1991</xref>; Stachowiak et al. <xref ref-type="bibr" rid="CR181">1996</xref>, <xref ref-type="bibr" rid="CR182">1998</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR164">2004</xref>). By site-directed mutagenesis, a cluster of positively charged amino acids at the C-termini has been identified as responsible for mtCK&#x2019;s ability to specifically attach to cardiolipin-containing membranes (Schlattner et al. <xref ref-type="bibr" rid="CR164">2004</xref>; Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>). Binding of mtCK with mitochondrial membranes takes place in two phases (Schlattner et al. <xref ref-type="bibr" rid="CR164">2004</xref>). The first phase of mtCK attachment is mediated by ionic interaction by positively charged amino acid clusters at the C-terminal of mtCK; the second slower phase is mediated by partial insertion of a hydrophobic stretch into the membrane bilayer (Schlattner et al. <xref ref-type="bibr" rid="CR165">2006a</xref>; Maniti et al. <xref ref-type="bibr" rid="CR113">2010</xref>). The ability of mtCK to bind to and cross-link two membranes explains the contact site formation between mitochondrial inner and outer membranes and the resulting mechanical stabilization of mitochondria as shown with liver mitochondria from transgenic mice expressing mtCK (Speer et al. <xref ref-type="bibr" rid="CR179">2005</xref>). Also, the formation of the characteristic crystalline intra-mitochondrial &#x201C;railway-track&#x201D; inclusions, built of mtCK octamers (Stadhouders et al. <xref ref-type="bibr" rid="CR183">1994</xref>) inside of mitochondria of &#x201C;ragged red fibres&#x201D; from patients with mitochondrial cytopathies, can be explained by membrane binding of mtCK octamers either peripherally between inner and outer membrane or in the cristae between inner membranes. Once bound to membranes, mtCK shows a pronounced tendency to form ordered 2D crystalline arrangements (Schnyder et al. <xref ref-type="bibr" rid="CR168">1994</xref>). These resemble the sheet-like crystalline inclusions in such patient&#x2019;s mitochondria (Stadhouders et al. <xref ref-type="bibr" rid="CR183">1994</xref>). Interestingly, these pathological intra-mitochondrial mtCK crystals that are formed as a result of a compensatory over-expression reaction to an energy deficit (O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR130">1997b</xref>), can also be induced after Cr depletion in adult cardiomyocytes by addition of guanidine propionic acid (GPA) (Eppenberger-Eberhardt et al. <xref ref-type="bibr" rid="CR56">1991</xref>). These mtCK inclusions, both in Cr-depleted cardiomyocytes and in mitochondrial myopathy patients, disappear upon Cr supplementation of the cell culture medium or the patients, respectively (Eppenberger-Eberhardt et al. <xref ref-type="bibr" rid="CR56">1991</xref>; Tarnopolsky et al. <xref ref-type="bibr" rid="CR194">2004</xref>). Finally, recent data show that mtCK, once bound to cardiolipin-containing membrane vesicles, is able to specifically cluster cardiolipin molecules around its molecular surface (Epand et al. <xref ref-type="bibr" rid="CR55">2007b</xref>) and, if cross-linked to a second membrane vesicle, mtCK is able to facilitate lipid exchange between the two membranes (Epand et al. <xref ref-type="bibr" rid="CR54">2007a</xref>). This of course seems relevant for the structure and physiology of mitochondrial inner/outer membrane contact sites and the pre-apoptotic process of mitochondrial permeability transition pore (MPTP) function.</p>
        </sec>
        <sec id="Sec15">
          <title>Control of mitochondrial permeability transition, stabilization of inner/outer mitochondrial membrane complex and anti-apoptotic effects of creatine</title>
          <p>As mentioned earlier, mtCK occupies strategically important dual locations in the intermembrane and the cristae space (Kottke et al. <xref ref-type="bibr" rid="CR99">1991</xref>). In the periphery of the mitochondrion, mtCK is part of a protein complex that is involved in the so-called mitochondrial permeability transition (MPT) pore complex (O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR129">1997a</xref>; Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>). Although the molecular composition of the pore remains an open question, it seems to involve the adenine nucleotide transporter ANT-1 isoform and the voltage-dependent anion carrier VDAC (Zhivotovsky et al. <xref ref-type="bibr" rid="CR238">2009</xref>) together with mtCK (Kroemer et al. <xref ref-type="bibr" rid="CR103">2007</xref>). MPT represents an early event in apoptosis that often leads to swelling of mitochondria and release of apoptosis-inducing factors that can be initiated experimentally by exposure of mitochondria to atractyloside, an inhibitor of ANT, and/or by elevation of extra-mitochondrial [Ca<sup>2+</sup>] (Azzolin et al. <xref ref-type="bibr" rid="CR9">2010</xref>). Under these conditions, isolated mitochondria from the liver of normal wild-type mice, which do not express mtCK in the liver, undergo swelling and apoptosis. This process can be inhibited by cyclosporine, a potent anti-apoptotic drug. On the other hand, transgenic mice that have been engineered to express mtCK in their liver are protected from apoptosis and its destructive consequences by simple addition of Cr or its analogue cyclocreatine that is also phosphorylated by the CK reaction (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>). The extent of protection by Cr is comparable to that of cyclosporine (Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>). Thus, Cr is not only involved in stimulating mitochondrial respiration but also works as an effective mitochondrial protectant and anti-apoptotic compound (Brdiczka et al. <xref ref-type="bibr" rid="CR20">2006</xref>). This may explain some of the cell-protective effects observed with Cr. For example, transgenic mice expressing mtCK in their liver acquire, after Cr supplementation, a remarkable tolerance against hypoxia (Miller et al. <xref ref-type="bibr" rid="CR121">1993</xref>) and liver toxins (Hatano et al. <xref ref-type="bibr" rid="CR73">1996</xref>), as well as against tumour necrosis factor-induced apoptosis (Hatano et al. <xref ref-type="bibr" rid="CR74">2004</xref>). Since PCr has been shown to bind to and protect biological membranes (Saks et al. <xref ref-type="bibr" rid="CR153">1996</xref>; Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR196">2003</xref>, <xref ref-type="bibr" rid="CR197">2005a</xref>), it is conceivable that the PCr generated by mtCK in the mitochondrial inter-membrane space would also bind to mitochondrial membranes and stabilize them against swelling, as this was shown for plasma membranes of erythrocytes (Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR196">2003</xref>, <xref ref-type="bibr" rid="CR197">2005a</xref>). Thus, mtCK plus Cr seem to exert cell protection not only by improving cellular energetics, but also by more or less energy-independent actions that also affect apoptosis (O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR129">1997a</xref>; Brdiczka et al. <xref ref-type="bibr" rid="CR20">2006</xref>) (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Mitochondrial permeability transition is inhibited by CK substrates. At a concentration of 10&#xA0;mM, the CK substrates creatine (Cr) and cyclocreatine (cCr), Cr-analogon, inhibit MTP in isolated mouse liver mitochondria to a comparable degree as 1&#xA0;&#x3BC;M cyclosporin A (CSA), the gold standard for MPT inhibition (Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>). The Cr-analogon guanidinopropionic acid (GPA) that is not accepted as a substrate by the CK reaction has no effect as compared to control without additions (none). Isolated liver mitochondria from transgenic mice expressing uMtCK in their liver were analysed by a swelling (light scattering) assay. They were energized with glutamate/malate in presence of 2mM&#xA0;Mg<sup>2+</sup> and then challenged by 120&#xA0;&#x3BC;M Ca<sup>2+</sup> where indicated. (Figure taken from Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref> with permission)</p></caption><graphic xlink:href="726_2011_877_Fig4_HTML" id="MO4"/></fig><table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p><bold>Pleiotropic effects of creatine for cell function and cell protection</bold></p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="2"><bold>Energy-related effects of creatine</bold></td></tr><tr><td align="left">&#xA0;Cr improves cellular energy state (PCr/ATP ratio) and muscle performance</td><td align="left">(Harris et al. <xref ref-type="bibr" rid="CR71">1992</xref>; Greenhaff et al. <xref ref-type="bibr" rid="CR63">1993</xref>)</td></tr><tr><td align="left">&#xA0;Cr facilitates intracellular energy transport (PCr circuit or shuttle)</td><td align="left">(Wallimann <xref ref-type="bibr" rid="CR217">1975</xref>; Saks et al. <xref ref-type="bibr" rid="CR151">1978</xref>, <xref ref-type="bibr" rid="CR156">2006b</xref>; Bessman and Geiger <xref ref-type="bibr" rid="CR18">1981</xref>; Wallimann and Eppenberger <xref ref-type="bibr" rid="CR219">1985</xref>; Bessman <xref ref-type="bibr" rid="CR16">1986</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR224">1992</xref>, <xref ref-type="bibr" rid="CR225">1998</xref>; Kaasik et al. <xref ref-type="bibr" rid="CR90">2003</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR226">2007</xref>)</td></tr><tr><td align="left">&#xA0;Cr improves the efficiency of cellular energy utilization (e.g. for Ca<sup>2+</sup>-handling)</td><td align="left">(Rossi et al. <xref ref-type="bibr" rid="CR146">1990</xref>; Steeghs et al. <xref ref-type="bibr" rid="CR184">1997</xref>; Pulido et al. <xref ref-type="bibr" rid="CR137">1998</xref>; van Leemputte et al. <xref ref-type="bibr" rid="CR210">1999</xref>)</td></tr><tr><td align="left">&#xA0;Cr stimulates mitochondrial respiration (improved energy provision)</td><td align="left">(Kay et al. <xref ref-type="bibr" rid="CR95">2000</xref>; Meyer et al. <xref ref-type="bibr" rid="CR120">2006</xref>)</td></tr><tr><td align="left">&#xA0;Cr stabilizes mitochondrial PTP complex and thus acts as mitochondrial protectant (anti-apoptotic)</td><td align="left">(O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR129">1997a</xref>; Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>; Hatano et al. <xref ref-type="bibr" rid="CR74">2004</xref>)</td></tr><tr><td align="left" colspan="2"><bold>Anti-oxidant and anti-apoptotic effects of creatine</bold></td></tr><tr><td align="left">&#xA0;Cr acts as a mild direct anti-oxidant (free radical scavenger)</td><td align="left">(Lawler et al. <xref ref-type="bibr" rid="CR108">2002</xref>)</td></tr><tr><td align="left">&#xA0;Cr acts as a strong indirect anti-oxidant in mitochondria (where ROS production is lowered by tight coupling of respiration/ATP production to ATP export)</td><td align="left">(Meyer et al. <xref ref-type="bibr" rid="CR120">2006</xref>; Sestili et al. <xref ref-type="bibr" rid="CR171">2006</xref>)</td></tr><tr><td align="left">&#xA0;Cr reduces oxidative damage to DNA, specifically to mtDNA</td><td align="left">(Guidi et al. <xref ref-type="bibr" rid="CR69">2008</xref>)</td></tr><tr><td align="left">&#xA0;Cr up-regulates enzymes for oxidative stress defence</td><td align="left">(Young et al. <xref ref-type="bibr" rid="CR235">2010</xref>)</td></tr><tr><td align="left">&#xA0;Cr strongly protects in vivo from mitochondrial toxins (Rotenone &amp; Paraquat)</td><td align="left">(Hosamani et al. <xref ref-type="bibr" rid="CR81">2010</xref>)</td></tr><tr><td align="left">&#xA0;Cr stabilizes mitochondrial PTP complex and thus acts as mitochondrial protectant (anti-apoptotic)</td><td align="left">(O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR129">1997a</xref>; Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>; Hatano et al. <xref ref-type="bibr" rid="CR74">2004</xref>)</td></tr><tr><td align="left" colspan="2"><bold>Other effects of creatine</bold></td></tr><tr><td align="left">&#xA0;Cr induces differential expression of transcription factors and other genes</td><td align="left">(Hespel et al. <xref ref-type="bibr" rid="CR78">2001</xref>; Louis et al. <xref ref-type="bibr" rid="CR112">2004</xref>; Deldicque et al. <xref ref-type="bibr" rid="CR46">2008</xref>; Safdar et al. <xref ref-type="bibr" rid="CR148">2008</xref>)</td></tr><tr><td align="left">&#xA0;Cr reduces the appearance of inflammation markers during endurance exercise</td><td align="left">(Santos et al. <xref ref-type="bibr" rid="CR157">2004</xref>; Bassit et al. <xref ref-type="bibr" rid="CR11">2008</xref>)</td></tr><tr><td align="left">&#xA0;Cr activates cell signalling and enhances muscle cell differentiation</td><td align="left">(Ceddia and Sweeney <xref ref-type="bibr" rid="CR33">2004</xref>; Louis et al. <xref ref-type="bibr" rid="CR112">2004</xref>; Deldicque et al. <xref ref-type="bibr" rid="CR45">2007</xref>, <xref ref-type="bibr" rid="CR46">2008</xref>)</td></tr><tr><td align="left">&#xA0;Cr lowers homocysteine levels and lipid peroxidation (heart risk factors)</td><td align="left">(Deminice et al. <xref ref-type="bibr" rid="CR47">2009</xref>)</td></tr><tr><td align="left">&#xA0;Cr acts as an osmolyte, protecting cells against hypertonic stress</td><td align="left">(Alfieri et al. <xref ref-type="bibr" rid="CR4">2006</xref>)</td></tr><tr><td align="left">&#xA0;PCr binds to cell membranes and stabilizes and protects erythrocyte cell membranes</td><td align="left">(Saks et al. <xref ref-type="bibr" rid="CR153">1996</xref>; Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR196">2003</xref>, <xref ref-type="bibr" rid="CR197">2005a</xref>)</td></tr></tbody></table></table-wrap></p>
        </sec>
      </sec>
      <sec id="Sec16">
        <title>Phenotypes of CK knockout mice point to important cellular functions of CK and the PCr/Cr system</title>
        <p>Ablation of a given gene in transgenic knockout animals is a valuable tool to possibly evaluate the functions of this specific gene, or the respective protein coded by this gene, in an animal. The various constitutive CK knockouts, engineered by the Wieringa Group in Nijmegen NL, illustrates the phenotypical defects caused by the deletion of CK. Ablation of smtCK in muscle is a good example for a positive identification of a CK function. The fact that mtCK is required for stimulation of mitochondrial respiration by Cr (Saks et al. <xref ref-type="bibr" rid="CR154">2000</xref>) has been unambiguously corroborated by this technology with mtCK-deficient or double CK knockout mice (Kay et al. <xref ref-type="bibr" rid="CR95">2000</xref>).</p>
        <sec id="Sec17">
          <title>Adaptation and compensation effects alter knockout phenotypes</title>
          <p>Gene ablation may lead to complex adaptations in the organism to compensate for the loss of function related to the knocked out gene. Some very interesting compensatory events take place in the absence of CK function. In the constitutive CK knockouts, this may lead to a physiological and phenotypical amelioration of the phenotype, thus often hindering the phenotypic expression of a dysfunction related to CK deletion. As an example for phenotypic compensation, knocking out of CK in muscle leads to marked changes in mRNA expression profiles involving nuclear and mitochondrial mRNA species that are relevant for bioenergetics (de Groof et al. <xref ref-type="bibr" rid="CR43">2001b</xref>), as well as to altered expression of proteins involved in the glycolytic network and mitochondria (de Groof et al. <xref ref-type="bibr" rid="CR42">2001a</xref>). Double knock-out of cytosolic and smtCK in muscle also leads to remarkable compensatory adaptation of muscle structure and metabolism, e.g. in white, glycolytic Type II muscle fibres, which normally do not contain large numbers of mitochondria, the CK double knockout animals show a vastly increased mitochondrial propensity and a positioning of these large numbers of mitochondria in such a way that each myofibril is almost completely surrounded by contiguous rows of mitochondria. Thus, these transgenic &#x201C;glycolytic&#x201D; muscle fibres look rather like entirely oxidative insect flight muscle (Veksler et al. <xref ref-type="bibr" rid="CR212">1995</xref>; Ventura-Clapier et al. <xref ref-type="bibr" rid="CR215">1995</xref>; Steeghs et al. <xref ref-type="bibr" rid="CR185">1998</xref>; Ventura-Clapier et al. <xref ref-type="bibr" rid="CR216">2004</xref>; Novotova et al. <xref ref-type="bibr" rid="CR127">2006</xref>). This points to a compensation in the CK knockouts for reducing diffusion distances for ATP from the mitochondria to the contractile apparatus and thus would support the proposed function of the PCr shuttle that normally compensates for the diffusion limitations of adenine nucleotides via shuttling of PCr and Cr. This notion is fully supported by detailed analysis of energy provision in CK knockouts, e.g. by the propinquity of mitochondria to myofibrils enabling ATP/ADP to be channelled directly from mitochondria to myofibrils and back (Kaasik et al. <xref ref-type="bibr" rid="CR90">2003</xref>). In addition, the glyocogen content in these muscles is elevated indicating that instead of PCr, glycogen/glucose is taken as a more or less immediate source of energy for muscle contraction. Such interesting compensatory alterations give new insight into the kinds of problems that may have been generated in a given tissue by knocking out of either cytosolic and/or mitochondrial CK.</p>
          <p>A further interesting observation relates to the fact that CK exists as isoforms and that in a given cell usually a cytosolic CK isoform is co-expressed with a mitochondrial mtCK isoform, although the relative proportion may vary depending on cell type and organ (Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>). After knocking out one CK isoform only the other CK isoform can at least partially compensate for the function of the other, e.g. cytosolic CK can partially compensate for mtCK (Watchko et al. <xref ref-type="bibr" rid="CR228">2000</xref>).</p>
        </sec>
        <sec id="Sec18">
          <title>Muscle phenotypes of CK deficiency</title>
          <p>The most obvious CK knockout phenotypes in muscle relate (a) to force development and maintenance, as well as force&#x2013;velocity relationship, and (b) to muscle relaxation and Ca<sup>2+</sup>-handling, as well as to (c) CK-mediated membrane metabolic sensing. As to the first, transgenic mice that are completely deficient in muscle CK lack burst activity (van Deursen et al. <xref ref-type="bibr" rid="CR206">1993</xref>). The velocity and extent of muscle shortening, power and work after the initial series of stimuli are also significantly lower in the CK knockouts compared to wild type (Watchko et al. <xref ref-type="bibr" rid="CR228">2000</xref>). In transgenic mice with graded reduction of CK, muscle burst activity is reduced proportionally to the lowered levels of CK expression (van Deursen et al. <xref ref-type="bibr" rid="CR207">1994</xref>). These data are in line with findings that MM-CK is specifically localized at the M-band of sarcomeric muscle, where it regenerates in situ the ATP used for muscle contraction (Saks et al. <xref ref-type="bibr" rid="CR152">1984</xref>; Wallimann et al. <xref ref-type="bibr" rid="CR221">1984</xref>). In non-muscle cells, ablation of BB-CK leads to altered actin-based phagocytosis (Kuiper et al. <xref ref-type="bibr" rid="CR104">2008</xref>) and cell motility of cells cultured from CK knockout animals (Kuiper et al. <xref ref-type="bibr" rid="CR105">2009</xref>), indicating that CK is not only important for muscle contraction but also for phagocytosis and cell motility in general. As to the second, in CK knockout muscle, muscle relaxation time was longer, with changes also in intracellular Ca<sup>2+</sup>-handling in transgenic muscle cells (Steeghs et al. <xref ref-type="bibr" rid="CR184">1997</xref>). In line with earlier findings that CK is crucially involved in local ATP regeneration in the vicinity of the SR Ca<sup>2+</sup>-ATPase pump (Rossi et al. <xref ref-type="bibr" rid="CR146">1990</xref>), it was shown with CK knockout mice that the CK system is indeed essential for optimal refill of the SR Ca<sup>2+</sup> store in skeletal muscle (de Groof et al. <xref ref-type="bibr" rid="CR44">2002</xref>). According to more recent data, CK, however, is not only important for Ca<sup>2+</sup> cycling in muscle, but also in the brain, as shown with brain CK knockouts, where brain Ca<sup>2+</sup> kinetics were affected (Streijger et al. <xref ref-type="bibr" rid="CR189">2010</xref>). Interestingly, Cr supplementation of myogenic cells from mdx dystrophic mice improves intracellular Ca<sup>2+</sup> handling (Pulido et al. <xref ref-type="bibr" rid="CR137">1998</xref>) and Cr supplementation of athletes results in shortening of muscle relaxation times in vivo, presumably by improving SR-Ca<sup>2+</sup>-pump function and intracellular Ca<sup>2+</sup> handling (van Leemputte et al. <xref ref-type="bibr" rid="CR210">1999</xref>). The fact that elevating total Cr concentration in muscle by Cr supplementation of human subjects leads to an increase in muscle force and to faster muscle relaxation and recovery after exhaustive exercise, compared with non-supplemented subjects (see below), is fully in line with the described functions of the CK isoforms. In addition, these data indicate that by Cr supplementation, the efficiency of the respective subcellular CK micro-compartments can be improved via elevation of the PCr pool size. Finally, as to the third, by transgenic deletion of cytosolic MM-CK the observed integrative signalling through CK, where cellular energetics is coupled to membrane metabolic sensing, is lost (Abraham et al. <xref ref-type="bibr" rid="CR1">2002</xref>). This would corroborate the importance of CK for metabolic sensing and signalling at the plasma membrane.</p>
        </sec>
        <sec id="Sec19">
          <title>Brain phenotypes of CK deficiency</title>
          <p>Besides being expressed in all brain cells, real &#x201C;hot spots&#x201D; of CK expression and localization are Bergman glia and Purkinje cells in the cerebellum that are important for movement coordination and control, as well as neuronal cells in the hippocampus, where learning and memory functions reside, and finally epithelial cells in the choroid plexus that are rich in ATP-dependent pumps for homeostasis of ions and metabolites between the ventricular fluid/brain interface (Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>; Kaldis et al. <xref ref-type="bibr" rid="CR91">1996a</xref>). Accordingly, brain CK knockouts that present with permanently reduced body weight, as well as with altered brain morphology, display altered behaviour, e.g. low nest-building activity, less exploratory activity, less grooming, etc. and neurological difficulties in spatial learning and memory functions (Jost CR et al. <xref ref-type="bibr" rid="CR89">2002</xref>; in &#x2018;t Zandt et al. <xref ref-type="bibr" rid="CR85">2004</xref>; Streijger et al. <xref ref-type="bibr" rid="CR187">2005</xref>).</p>
          <p>Recent data also show that the same animals present with problems concerning thermoregulation, eventually succumbing to a sudden and severe drop in body temperature (Streijger et al. <xref ref-type="bibr" rid="CR188">2009</xref>). With respect to the involvement of CK in thermoregulation, it is interesting to observe that Cr supplementation in endurance athletes improved their performance during exhausting exercise under hot conditions. That is, in responders, whose muscle total Cr increased during supplementation, rectal temperature and heart rate lowered and peripheral key modulators and indices for the brain neurotransmitters, serotonin and dopamine, were influenced. The subjects in the Cr group reacted with reduced effort perception and completed the endurance task more easily compared to controls (Hadjicharalambous et al. <xref ref-type="bibr" rid="CR70">2008</xref>). At the same time, Cr reduced inflammatory and muscle soreness markers after a 30 km race (Santos et al. <xref ref-type="bibr" rid="CR157">2004</xref>).</p>
          <p>Ablation of the genes for brain-type B-CK and ubiquitous mtCK in mice also leads to frequency-dependent hearing loss and problems with vestibular functions (Shin et al. <xref ref-type="bibr" rid="CR173">2007</xref>), which is in line with the very high concentrations of CK found in the respective cellular structures of the inner ear. Interestingly, Cr supplementation significantly attenuated noise-induced hearing loss (Minami et al. <xref ref-type="bibr" rid="CR123">2007</xref>). Finally, brain CK knockout has demonstrated the importance of CK for the energetics of bone metabolism and osteoclast function for bone resorption (Chang et al. <xref ref-type="bibr" rid="CR35">2008</xref>). This complements earlier results concerning the expression of CK in osteoblasts and the beneficial action of Cr on survival, differentiation and mineralization of osteoblasts in culture (Gerber et al. <xref ref-type="bibr" rid="CR59">2005</xref>), as well as with the stimulating effects of Cr on collagen type I synthesis and osteoprotegerin secretion of healthy and osteoporotic human osteoblasts (Gerber et al. <xref ref-type="bibr" rid="CR60">2008</xref>).</p>
          <p>Thus, it seems obvious that CK takes over specific functions in almost every cell of the body, except for liver, where under normal healthy conditions no CK is expressed (Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>). Surprisingly, after the first brain CK knockout transgenic mice became available, it took almost 10 years to figure out some of the most prominent phenotypes of this type of transgenic mice. Probably, it will take another decade still to discover the more subtle phenotypic changes, gone unnoticed, which are caused by brain-type CK ablation.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec20">
      <title>Creatine&#x2014;nutritional constituent and supplementation</title>
      <sec id="Sec21">
        <title>Pleiotropic effects of creatine</title>
        <p>Abrogation of CK enzymes in transgenic mice (see above) or depletion of the substrate Cr in Cr-analogue-fed (GPA) animals, respectively, both show muscle phenotypes with similar functional deficits (Mekhfi et al. <xref ref-type="bibr" rid="CR118">1990</xref>; Wyss and Wallimann <xref ref-type="bibr" rid="CR234">1994</xref>; O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR128">1996</xref>, <xref ref-type="bibr" rid="CR130">1997b</xref>; Steeghs et al. <xref ref-type="bibr" rid="CR184">1997</xref>, <xref ref-type="bibr" rid="CR185">1998</xref>). The affected functions, such as the development of muscle force and muscle relaxation, including intracellular Ca<sup>2+</sup> handling, can be enhanced in wild-type animals, as well as in humans, by Cr supplementation (Kraemer and Volek <xref ref-type="bibr" rid="CR100">1999</xref>; van Leemputte et al. <xref ref-type="bibr" rid="CR210">1999</xref>). These mostly energy-related ergogenic effects of Cr in sports, based on the seminal work by Harris and Greenhaff in the early nineties (Harris et al. <xref ref-type="bibr" rid="CR71">1992</xref>; Greenhaff et al. <xref ref-type="bibr" rid="CR63">1993</xref>), are well known and in the meantime widely accepted (Kamber et al. <xref ref-type="bibr" rid="CR94">1999</xref>). The same holds true for the effects of Cr for rehabilitation (Hespel et al. <xref ref-type="bibr" rid="CR78">2001</xref>; Johnston et al. <xref ref-type="bibr" rid="CR88">2009</xref>) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). However, a number of potentially beneficial effects of Cr, which are not directly related to enhancement of cellular energetics, have emerged, for example the protective effects of Cr on mitochondrial permeability transition pore opening (O&#x2019;Gorman et al. <xref ref-type="bibr" rid="CR129">1997a</xref>; Dolder et al. <xref ref-type="bibr" rid="CR49">2003</xref>), an early event in apoptosis, or the antioxidant effects of Cr, as well as the interference of Cr with cell signalling affecting the expression of muscle transcriptional factors (Hespel et al. <xref ref-type="bibr" rid="CR78">2001</xref>; Hespel and Derave <xref ref-type="bibr" rid="CR77">2007</xref>; Deldicque et al. <xref ref-type="bibr" rid="CR46">2008</xref>) or activating important signalling pathways such a p38 Akt/PKB (Hespel et al. <xref ref-type="bibr" rid="CR78">2001</xref>; Deldicque et al. <xref ref-type="bibr" rid="CR45">2007</xref>; Hespel and Derave <xref ref-type="bibr" rid="CR77">2007</xref>; Deldicque et al. <xref ref-type="bibr" rid="CR46">2008</xref>) or AMPK (Ceddia and Sweeney <xref ref-type="bibr" rid="CR33">2004</xref>) (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
        <p>Such beneficial effects of Cr may also alleviate toxic drug effects that target bioenergetics and mitochondria, such as the anti-cancer drug doxorubicin (Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR163">2002</xref>, <xref ref-type="bibr" rid="CR199">2006</xref>). Doxorubicin accumulates in mitochondria and affects their functions including inhibition of CK isoforms (Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR163">2002</xref>; Tokarska-Schlattner et al. <xref ref-type="bibr" rid="CR198">2005b</xref>, <xref ref-type="bibr" rid="CR200">2007</xref>). In an animal study, Cr supplementation in combination with vitamins was able to increase survival of doxorubicin-treated rats (Santos et al. <xref ref-type="bibr" rid="CR158">2007</xref>).</p>
        <p>The pleiotropic effects of Cr on muscle growth and muscle performance have been documented in more than 400 publications to date. Cr has a scientifically unambiguously proven record of being a truly ergogenic nutritional supplement that reaches the target organs, elevates muscle total Cr and PCr pools, leads to an increase in muscle mass and elevates muscle performance in a number of sports (for reviews, see the position stands of the International Society of Sports Nutrition: Buford et al. <xref ref-type="bibr" rid="CR27">2007</xref>; Kerksick et al. <xref ref-type="bibr" rid="CR97">2008</xref>). The effects of Cr are most beneficial for high-intensity intermittent exercise (Kraemer and Volek <xref ref-type="bibr" rid="CR100">1999</xref>) but positive effects of Cr have also been noted for better fatigue resistance (Rawson et al. <xref ref-type="bibr" rid="CR142">2011</xref>) and for improved recovery after heavy exercise (Yquel et al. <xref ref-type="bibr" rid="CR236">2002</xref>). It has also been realized that Cr could alleviate or spare muscle damage and inflammation caused by excessive endurance performance experienced in an ironman competition (Bassit et al. <xref ref-type="bibr" rid="CR11">2008</xref>; see also Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). It is important to note that the mostly anecdotal side effects of Cr supplementation that are reported, e.g. via internet can be dismissed on the basis of solid scientific evidence, even if Cr is taken for extended periods of time (i.e. years), (Kreider et al. <xref ref-type="bibr" rid="CR102">2003</xref>; Francaux and Poortmans <xref ref-type="bibr" rid="CR57">2006</xref>; Persky and Rawson <xref ref-type="bibr" rid="CR134">2007</xref>; Bender et al. <xref ref-type="bibr" rid="CR12">2008a</xref>). However, the most relevant issue with respect to potential side effects of Cr, namely the chemical purity of the Cr used, is definitely an issue (Pischel and Gastner <xref ref-type="bibr" rid="CR135">2007</xref>). Many of the pleiotropic effects of Cr for sports, health and disease are discussed in detail in this volume. Here, we would like to point out some potentially important new applications of Cr supplementation and their potential socio-economic implications for humans and for the global ecosystem.</p>
      </sec>
      <sec id="Sec22">
        <title>Creatine supplementation for normal healthy people?</title>
        <p>The protective effects of Cr as an adjuvant therapeutic intervention in disease states, such as neuromuscular, neuro-degenerative diseases, as well as muscle- and neuro-rehabilitation, have been recently reviewed in a special volume of &#x201C;Subcellular Biochemistry&#x201D; (&#x201C;Creatine and Creatine Kinase in Health and Disease&#x201D;, edited by G. Salomons and M. Wyss). In particular, the neuroprotective role of Cr that is relevant to a number of neuromuscular and neuro-degenerative diseases is well documented (Matthews et al. <xref ref-type="bibr" rid="CR114">1998</xref>; Klivenyi et al. <xref ref-type="bibr" rid="CR98">1999</xref>; Brewer and Wallimann <xref ref-type="bibr" rid="CR21">2000</xref>; Wyss and Kaddurah-Daouk <xref ref-type="bibr" rid="CR232">2000</xref>; Baker and Tarnopolsky <xref ref-type="bibr" rid="CR10">2003</xref>; Andres et al. <xref ref-type="bibr" rid="CR6">2005a</xref>, <xref ref-type="bibr" rid="CR7">b</xref>; Brosnan and Brosnan <xref ref-type="bibr" rid="CR23">2007</xref>; Rodriguez et al. <xref ref-type="bibr" rid="CR144">2007</xref>; Tarnopolsky <xref ref-type="bibr" rid="CR193">2007</xref>; Adhihetty and Beal <xref ref-type="bibr" rid="CR3">2008</xref>; Andres et al. <xref ref-type="bibr" rid="CR8">2008</xref>; Valastro et al. <xref ref-type="bibr" rid="CR204">2009</xref>; Gualano et al. <xref ref-type="bibr" rid="CR67">2010</xref>).</p>
        <p>Little has been mentioned so far of the potential benefits of Cr supplementation for normal healthy people. In a placebo-controlled, randomized animal study, it was shown in fact that life-long Cr supplementation, even at very high daily dosage, is of significant benefit to life expectancy and most importantly also for life quality of normal healthy mice (Bender et al. <xref ref-type="bibr" rid="CR12">2008a</xref>). In a recent study with human subjects, glucose tolerance in healthy sedentary males undergoing aerobic training was improved by Cr supplementation. Thus, a change in life-style together with intake of Cr may prevent or delay the onset of health problems, such as type-2 diabetes, obesity and metabolic syndrome (Gualano et al. <xref ref-type="bibr" rid="CR65">2008a</xref>).</p>
        <p>Cr supplementation, in conjunction with exercise, was shown to improve muscle performance in elderly men and postmenopausal women (Gotshalk et al. <xref ref-type="bibr" rid="CR61">2002</xref>, <xref ref-type="bibr" rid="CR62">2008</xref>), as well as to increase bone mineral density in healthy elderly men (Chilibeck et al. <xref ref-type="bibr" rid="CR36">2005</xref>). This is in line with the findings that Cr increases survival, metabolic activity, as well as mineralization of cultured osteoblast cells in vitro (Gerber et al. <xref ref-type="bibr" rid="CR59">2005</xref>). Thus, Cr may not only be beneficial for muscle but also for bone health of normal healthy people. It is entirely conceivable that Cr supplementation could alleviate or prevent osteopenia and/or osteoporosis of postmenopausal women (Gerber et al. <xref ref-type="bibr" rid="CR59">2005</xref>, <xref ref-type="bibr" rid="CR60">2008</xref>), as Cr has been shown to stimulate collagen type I synthesis and secretion of osteoprotegerin in human bone cells derived from osteopenic subjects (Gerber et al. <xref ref-type="bibr" rid="CR60">2008</xref>).</p>
        <p>Positive effects of Cr supplementation on memory, learning and mental performance (Rae et al. <xref ref-type="bibr" rid="CR140">2003</xref>), as well as on cognitive performance, have been demonstrated (McMorris et al. <xref ref-type="bibr" rid="CR116">2007</xref>), and a reduction of mental fatigue by Cr was also shown (Watanabe et al. <xref ref-type="bibr" rid="CR227">2002</xref>).</p>
      </sec>
      <sec id="Sec23">
        <title>Creatine for the elderly?</title>
        <p>A simple and inexpensive intervention, a daily supplementation with 2&#x2013;5 g of chemically pure Cr for healthy adults and most importantly for senior and elderly people (Gotshalk et al. <xref ref-type="bibr" rid="CR61">2002</xref>, <xref ref-type="bibr" rid="CR62">2008</xref>), is likely to contribute as a preventive measure to muscle, bone and brain health, potentially saving billions of dollars otherwise spent for rehabilitation measures following accidents (Hespel and Derave <xref ref-type="bibr" rid="CR77">2007</xref>; Dalbo et al. <xref ref-type="bibr" rid="CR40">2009</xref>). Cr supplementation seems especially relevant for elderly, who often eat much less or no meat at all and thus likely have low tissue Cr levels, as limited data from vegans and vegetarians indicates (Burke et al. <xref ref-type="bibr" rid="CR28">2003</xref>; Watt et al. <xref ref-type="bibr" rid="CR229">2004</xref>). Recent nutritional recommendations by the US Society for Sarcopenia, Cachexia and Wasting Disease proposed Cr supplementation together with other measures for the management of sarcopenia (age-dependent progressive muscle loss) which is prevalent among the elderly (Morley et al. <xref ref-type="bibr" rid="CR124">2010</xref>). Interestingly, 2&#xA0;weeks of 4&#xA0;&#xD7;&#xA0;5&#xA0;g of Cr daily improved cognitive performance in the elderly (McMorris et al. <xref ref-type="bibr" rid="CR116">2007</xref>). With respect to the possible beneficial effects of Cr supplementation that have been discussed for elderly (Dalbo et al. <xref ref-type="bibr" rid="CR40">2009</xref>), it is important to note that Cr acts as an osmolyte. Since Cr is taken up by the osmotically active sodium and chloride dependent CRT, concomitant import of NaCl into the target cells may lead to at least a temporary increase in the intracellular water content (Ziegenfuss et al. <xref ref-type="bibr" rid="CR239">1998</xref>). Hydration is an important physiological parameter in humans that gradually decreases with age (Aloia et al. <xref ref-type="bibr" rid="CR5">1998</xref>). However, in order to substantiate these preliminary results, many highly relevant to disease prevention and potentially with significant socio-economical health benefits, multi-centre epidemiological studies involving hundreds or thousands of subjects over prolonged periods of time would be necessary. Such studies would be expensive undertakings. However, as Cr promises only negligible financial returns to pharmaceutical companies, such studies would most likely have to be funded by government agencies.</p>
      </sec>
      <sec id="Sec24">
        <title>Creatine as a prominent nutritional constituent for man since prehistoric times</title>
        <p>Concerning possible health benefits for healthy people, a legitimate question that may be asked is whether modern man, due to greatly changed eating habits, is justified in supplementing the diet with additional Cr particularly when this can be synthesised endogenously and obtained through a balanced meat and fish diet. To possibly answer this question we need to examine early hominid nutrition. A recent archaeological survey in Ethiopia brought to light stone-tool inflicted cut and percussion marks on ungulate bones that were dated to older than 3.39 million years. These, the oldest findings of this kind, after careful microscopic examination were identified as being the result of early hominid stone tools used for removing flesh from bones and for retrieving bone marrow (McPherron et al. <xref ref-type="bibr" rid="CR117">2010</xref>). These findings indicate that <italic>Australopithecus afarensis</italic> already practised butchery of large animals and consumed meat some 3.4 million years ago.</p>
        <p>Humans have clearly evolved as carnivores/omnivores, ingesting large quantities of meat and fish, and thus necessarily also Cr, as a significant part of their diet (Broadhurst et al. <xref ref-type="bibr" rid="CR22">1998</xref>; Richards <xref ref-type="bibr" rid="CR143">2002</xref>). There is evidence that evolutionarily human brain development and growth were strongly dependent on the availability of high-quality food, such as meat and/or fish, representing nutritionally rich sources of protein, fatty acids, vitamins and minerals (Milton <xref ref-type="bibr" rid="CR122">2003</xref>) and incidentally also of Cr. Evidence from isotopic analysis of skeletons of Neanderthals and modern Palaeolithic and Mesolithic humans highlights the importance of meat and fish in the hominid diet (Richards <xref ref-type="bibr" rid="CR143">2002</xref>). When successful at hunting or fishing, these hominids as true carnivores/omnivores, most likely devoured more than 1&#x2013;2&#xA0;kg of meat or fish per day during prolonged periods of time during the year, ingesting at least 5&#x2013;10&#xA0;g or more of Cr daily. The combination of high-quality diet and the higher proportion of maternal daily energy budget invested in the growing embryo during pregnancy of prehistoric women, would additionally have allowed for greater body weight as well as larger brain size (encephalization) relative to body weight of the infant at birth, compared with other primates (Ulijaszek <xref ref-type="bibr" rid="CR203">2002</xref>; Carlson and Kingston <xref ref-type="bibr" rid="CR32">2007</xref>). With respect to Cr, it is known that endogenous synthesis of Cr is energetically costly in terms of methyl-group equivalents. Carnivores/omnivores ingesting large amounts of Cr thus spare a significant proportion of the energy needed for acquisition of reactive methyl group equivalents in the form of <italic>S</italic>-adenosyl-<sc>l</sc>-methionine (AdoMet) that can be used for other anabolic synthetic pathways (Brosnan et al. <xref ref-type="bibr" rid="CR24">2007a</xref>, <xref ref-type="bibr" rid="CR25">b</xref>).</p>
        <p>It, therefore, seems that the evolutionary path of hominid development is tightly linked to food quality, e.g. to ingesting large amounts of meat and fish and concomitantly also of Cr. One might surmise from this that Cr supplementation should also belong to the nutritional requirements of modern man, depending on how much meat and/or fish is actually ingested daily. Depending on the cultural and economic background, the present daily meat consumption varies from zero (vegans) to approximately 150&#xA0;g (Switzerland) or 250&#x2013;300&#xA0;g (USA, Australia) of meat/person/day (numbers include not only fresh but also processed meat that is known to contain much less Cr than fresh meat, or even none at all). These numbers correspond to a daily Cr consumption per person from zero to about 0.75&#x2013;1.5&#xA0;g and are clearly at the lower end of daily alimentary requirements for Cr that may be in the order of 2&#x2013;4&#xA0;g/person/day (see European Food Safety Authority web site: <ext-link ext-link-type="uri" xlink:href="http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620761727.htm">http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620761727.htm</ext-link>).</p>
        <p>Finally, the fact that in most people who ingest extra Cr the total Cr pool size (Cr&#xA0;+&#xA0;PCr) in muscle is elevated by 5&#x2013;20% indicates that in these the Cr pools are not saturated. This alone could be taken as an argument that even normal healthy people should supplement with Cr. The fact that meat consumption is recommended to be lowered globally for health (cf. high cholesterol, etc.) and ecological reasons lends additional support to the argument for Cr supplementation of the diet.</p>
      </sec>
      <sec id="Sec25">
        <title>Foetal creatine metabolism and supply during pregnancy</title>
        <p>Using a special precocial mouse strain, the spiny mouse (<italic>Acomys cahirinus</italic>) with a longer pregnancy than that of normal mice, closely resembling human pregnancy, it was convincingly shown that Cr supplementation protects the brain of the mouse pups in vivo against hypoxia and thus significantly enhances survival of the offspring (Ireland et al. <xref ref-type="bibr" rid="CR86">2008</xref>). This corroborates earlier findings that Cr protects the brain of newborn rats against hypoxia (Adcock et al. <xref ref-type="bibr" rid="CR2">2002</xref>) or of adult mice in a model of stroke (Prass et al. <xref ref-type="bibr" rid="CR136">2007</xref>). Also, Cr displayed astonishingly positive effects in traumatic brain injury in animals (Sullivan et al. <xref ref-type="bibr" rid="CR190">2000</xref>; Hausmann et al. <xref ref-type="bibr" rid="CR75">2002</xref>), as well as in children and adolescent patients (Sakellaris et al. <xref ref-type="bibr" rid="CR149">2006</xref>). Maternal Cr supplementation from mid-pregnancy onwards has most recently been shown to protect the diaphragm of the newborn spiny mouse from intra-partum hypoxia-induced damage (Cannata et al. <xref ref-type="bibr" rid="CR29">2010</xref>).</p>
        <p>What is new in the spiny mouse study is the fact that pregnant dams were fed Cr. This orally fed Cr is actively transported into the foetus via placental CRT (Ireland et al. <xref ref-type="bibr" rid="CR87">2009</xref>). Cr supplementation of the pregnant dam leads to an enhancement of total Cr levels in most organs, not only of the mother but also of the embryo, including the brain and thus protects the precocial mouse pups from episodes of hypoxia during a simulated hypoxic birth (Ireland et al. <xref ref-type="bibr" rid="CR86">2008</xref>; Cannata et al. <xref ref-type="bibr" rid="CR29">2010</xref>). These are important findings indicating that Cr supplementation during pregnancy may be a general protective measure to lower the incidence of brain damage and enhance survival also of human babies that go through periods of anoxia during birth or are at high-risk for an ischemic/anoxic birth to start with. Thus, it is entirely conceivable that the protective effects of Cr that are observed with experimental animals will also hold true for humans.</p>
        <p>In line with this hypothesis is the fact that endogenous Cr synthesis in the spiny mouse foetus gradually develops, but only reaches a mature level some time after birth (Ireland et al. <xref ref-type="bibr" rid="CR87">2009</xref>). The placenta expresses relatively high amounts of Cr transporter (CRT) and the expression of CRT in the placenta is high during the entire pregnancy and increases even more before birth (Ireland et al. <xref ref-type="bibr" rid="CR87">2009</xref>). This indicates that a significant part of embryonic Cr is taken up via the placenta and endogenous Cr synthesis in the foetus is not yet fully established. Thus, it can be concluded that the spiny mouse foetus depends on Cr delivered by the mother via her placenta. Although Cr is basically free of significant side effects, the dosage of Cr, used in the experiments with spiny mice described above, was very high with 5%, (w/w) in the food. This amounts, depending on how much food a pregnant mouse consumes, to an equivalent of 20&#x2013;50&#xA0;g of Cr or more per day for an adult human. This, on the other hand, demonstrates that Cr is safe also at high dosages, even for the foetus, which is in line with a study using Cr supplementation for premature babies in a clinical set-up, where no serious side effects of Cr had been observed in preterm babies (Bohnhorst et al. <xref ref-type="bibr" rid="CR19">2004</xref>).</p>
        <p>In addition to the obvious benefits of Cr for the baby, Cr supplementation of the mother during pregnancy could additionally be of benefit for the build-up of a strong uterus during the third trimester, when the uterus energetically matures by implementing the CK system (Dawson and Wray <xref ref-type="bibr" rid="CR41">1985</xref>; Clark et al. <xref ref-type="bibr" rid="CR39">1993</xref>; Clark <xref ref-type="bibr" rid="CR38">1994</xref>; Wallimann and Hemmer <xref ref-type="bibr" rid="CR220">1994</xref>). This could help to ease birthing, which largely depends on the energy charge of uterine smooth muscle and thus also of the PCr pool size (Kumar et al. <xref ref-type="bibr" rid="CR106">1962</xref>), to develop sufficient muscle force for the expulsion of the embryo. Therefore, it may be legitimate to propose that Cr supplementation should be a standard regimen during pregnancy, as well as after birth, both for the pregnant and lactating mother, as well as for the baby. This would favour healthy brain development of the embryo and baby, as it is obvious that Cr-deficient patients suffer from severe developmental delay with accompanying mental retardation (Schulze <xref ref-type="bibr" rid="CR169">2003</xref>).</p>
      </sec>
      <sec id="Sec26">
        <title>Creatine as natural constituent of mother&#x2019;s milk</title>
        <p>Human colostrums and milk contain significant concentrations of Cr, in the range of 0.2 mM (Hulsemann et al. <xref ref-type="bibr" rid="CR83">1987</xref>; Peral et al. <xref ref-type="bibr" rid="CR133">2005</xref>). The same is true for cow and sow milk with approximately 0.8&#xA0;mM Cr (Sheffy et al. <xref ref-type="bibr" rid="CR172">1952</xref>; Hulsemann et al. <xref ref-type="bibr" rid="CR83">1987</xref>; Peral et al. <xref ref-type="bibr" rid="CR133">2005</xref>). Interestingly, in a detailed study on sow colostrums and milk throughout lactation and weaning, both Cr and PCr were identified at up to 1.5 and 1.2&#xA0;mM concentrations, respectively (Kennaugh et al. <xref ref-type="bibr" rid="CR96">1997</xref>). It seems that Cr values can vary significantly, depending on the analytical techniques used. In addition, the variation found in the absolute Cr values and the Cr/Crn ratio may indicate that not always fresh milk was analysed. Using non-destructive NMR methods and spectral peak assignments, however, a prominent proton NMR peak was identified as Cr in bovine milk (Hu et al. <xref ref-type="bibr" rid="CR82">2004</xref>), thus leaving no doubt that Cr is a genuine chemical constituent in fresh milk. It would be of importance to investigate in detail whether and how nutrition would influence the total Cr content in mother&#x2019;s milk.</p>
        <p>A 3- to 4-month-old baby of 5&#xA0;kg consumes approximately 800&#xA0;ml milk per day from the mother at 0.2&#xA0;mM Cr, or from cow milk, at 0.8&#xA0;mM Cr (Hulsemann et al. <xref ref-type="bibr" rid="CR83">1987</xref>), amounting to a Cr ingestion of 4 or 16&#xA0;mg Cr/kg body weight per day, respectively, which translates into approximately 0.3 or 1.2&#xA0;g of Cr per day, respectively, for an adult person. Considering the fact that a significant amount of creatinine (25% in cow milk and more than 50% in human milk) was also found that may have arisen from Cr break-down during pasteurization of the milk, one can assume the above values to be lower-limit estimates, such that the actual Cr in fresh milk and, concomitantly, also the Cr intake by infants would be higher by a factor of 2&#x2013;3 if really fresh milk were consumed.</p>
      </sec>
      <sec id="Sec27">
        <title>Creatine supplementation of the mother during pregnancy, and of baby formulas and infant nutrition?</title>
        <p>Cr is secreted by the mammary gland during lactation and has been shown to be absolutely required for normal brain development and brain function (see Wyss and Schulze <xref ref-type="bibr" rid="CR233">2002</xref>). According to recent data from rats, the rat mammary gland of dams does not synthesize the Cr to be secreted but is extracted from the circulation (Lamarre et al. <xref ref-type="bibr" rid="CR107">2010</xref>). Since there was no increase in endogenous Cr synthesis in the dams, this required an increase for the lactating mother of approximately 50% in alimentary Cr above the normal daily requirement. In rats, this is largely compensated by hyperphagia, as normal rat feed contains Cr that is introduced by dried meat and fish products (Lamarre et al. <xref ref-type="bibr" rid="CR107">2010</xref>). This suggests that pregnant, and even more so lactating mothers, who remain vegans or vegetarians during pregnancy and lactation, may suffer from an inadequate supply of Cr, which in turn may not be favourable for the development of the foetus and infant when nursing.</p>
        <p>In the above work, it was further shown that while Cr is substantially accumulated in the growing pups, only 12% of this was obtained from the mother&#x2019;s milk (Lamarre et al. <xref ref-type="bibr" rid="CR107">2010</xref>). Thus, the relatively high need for Cr in the rat pups clearly places a metabolic burden on them, since, as mentioned earlier, endogenous Cr synthesis is energy costly and may use as much as 40% of the total SAM available for trans-methylation reactions (Brosnan and Brosnan <xref ref-type="bibr" rid="CR23">2007</xref>; Brosnan et al. <xref ref-type="bibr" rid="CR24">2007a</xref>, <xref ref-type="bibr" rid="CR25">b</xref>). If this is also true for humans (Mudd et al. <xref ref-type="bibr" rid="CR125">2007</xref>), the legitimate question arises, as to whether supplementing lactating women with Cr and thus have them secrete more Cr into their mothers milk may relieve some of the metabolic burden of energy-costly endogenous Cr synthesis by the baby. The same would hold true with respect to supplementing baby food and infant nutrition with Cr in non-nursing mothers or after weaning.</p>
        <p>Except for soy-based baby milk, which is devoid of Cr, most of the baby formulas and follow-up baby nutrition preparations were found to contain Cr and Crn in a similar concentration range (0.3 and 0.1&#xA0;mM, respectively) as mother&#x2019;s milk, although with significant variations (Hulsemann et al. <xref ref-type="bibr" rid="CR83">1987</xref>). Thus, pending more thorough investigations, it may turn out to be advisable to control and eventually supplement not only purely vegetarian soy-based baby food, but also all infant nutrition products, with Cr. Interesting in this context is the fact that it was already noted in 1913 that &#x201C;the increase in body weight of a baby after birth was roughly proportional to the Cr excreted in the urine by the respective mothers and that the excreted Cr/Crn ratio of the urine increased proportionally with mammary gland activity&#x201D; (Mellanby <xref ref-type="bibr" rid="CR119">1913</xref>). Thus Cr, be it delivered via mothers milk or supplemented externally, seems generally beneficial for growth and development of the infant.</p>
        <p>Since Cr is definitely an important constituent in milk of mammals, including humans, it is hard to understand that there still exist baby formulas and early infant nutrition products, especially products based entirely on soy-bean, which do not contain any or only very little Cr. Changing this situation should be a high priority of International and European Child Nutrition Advisory Boards, and this should be an important focus of Cr research during the coming years. The socio-economic benefit of this and other Cr supplementation applications, e.g. for general skeleto-muscular- (Tarnopolsky <xref ref-type="bibr" rid="CR193">2007</xref>) and neuro-rehabilitation (Sakellaris et al. <xref ref-type="bibr" rid="CR149">2006</xref>) seems obvious since every infant spared from irreversible brain damage caused for example by ischemia/anoxia during a difficult birth (Adcock et al. <xref ref-type="bibr" rid="CR2">2002</xref>; Ireland et al. <xref ref-type="bibr" rid="CR86">2008</xref>, <xref ref-type="bibr" rid="CR87">2009</xref>; Cannata et al. <xref ref-type="bibr" rid="CR29">2010</xref>) is beyond reckoning, not to speak of the relief from suffering. The objection that Cr could have side effects on human babies and infants has no scientific foundation. In a recent clinical study with premature infants, who were given 200&#xA0;mg of Cr per kg body weight per day for 2&#xA0;weeks, a dose corresponding to 14&#xA0;g of Cr per day for an adult person of 70&#xA0;kg, the treatment was well tolerated and no side effects were noted (Bohnhorst et al. <xref ref-type="bibr" rid="CR19">2004</xref>). However, there is an urgent need of clinically controlled studies in the field to determine a physiologically acceptable Cr dose for use with infants.</p>
        <p>Children with a so-called Cr-deficiency syndrome, who have genetic defects either in one of the enzymes for endogenous Cr synthesis (AGAT or GAMT), or in the CRT, present with severe neurological symptoms, such as developmental and speech delay, mental retardation, autism and epilepsy (Schulze <xref ref-type="bibr" rid="CR169">2003</xref>), which is largely due to the complete absence of Cr in brain tissue. This emphasises the importance of Cr for normal brain development and function (Newmeyer et al. <xref ref-type="bibr" rid="CR126">2005</xref>) and, by implication, advocates the adoption of Cr supplementation for pregnant women, as well as for preterm babies and infants. It seems of utmost importance that Cr in infant food is recognized as an essential component of human nutrition and that its content in infant formulas should be mandatorily regulated and controlled.</p>
        <p>Finally, the clinical tests (from urine and blood) for Cr-deficiency should be mandatory for all newborns. By this strategy, infants with treatable Cr-deficiencies (in AGAT or GAMT, but not in CRT) could be helped to lead a normal life.</p>
      </sec>
      <sec id="Sec28">
        <title>Creatine supplementation of parenteral nutrition?</title>
        <p>Individuals, who are supported in intensive care units (ICU), as well as severely ill patients with a variety of disease states, e.g. cancer patients with cachexia, fully depend on parenteral food which ideally should include supplementary Cr if needs are to be met. Unfortunately, Cr has not yet been recognized as a nutrient to be included in parenteral food. In this way, atrophy of muscles, particularly intra-costal muscles and diaphragm, could be lessened in IUC patients that are supported by artificial ventilation. The longer artificial ventilation is implemented, the more difficulties such patients experience in resuming independent breathing. Since Cr has been shown to significantly alleviate muscle disuse atrophy (Johnston et al. <xref ref-type="bibr" rid="CR88">2009</xref>), it is to be expected that resumption of breathing and rehabilitation of ICU patients may also be positively influenced by Cr. The same, of course, holds true for severely ill patients presenting with cachexia, as often occurs for cancer patients. Parenteral supplementation with Cr would help to prevent the physiological sequelae of Cr depletion to be expected in such patients (Wyss and Wallimann <xref ref-type="bibr" rid="CR234">1994</xref>).</p>
      </sec>
      <sec id="Sec29">
        <title>Creatine for dialysis patients?</title>
        <p>As pointed out earlier, Cr is not toxic to the kidney but rather is important for kidney function itself, since the CK/PCr system supports ion-pumps and metabolite transporters in this organ that are responsible for ion balance and resorption of metabolites from the urine. Patients with chronic renal failure (CRF) undergoing dialysis, who for obvious reasons are advised to restrict meat consumption, may present after a certain time with an altered skeletal and cardiac muscle energy metabolism, being low or deficient in Cr and showing a low PCr/ATP ratio (Pastoris et al. <xref ref-type="bibr" rid="CR132">1997</xref>; Tagami et al. <xref ref-type="bibr" rid="CR192">1998</xref>; Ogimoto et al. <xref ref-type="bibr" rid="CR131">2003</xref>). It is known that these patients lose muscle mass, become weaker and experience chronic fatigue. For these reasons, supplementation of dialysis patients with Cr might be viewed as an adjuvant therapy that should be implemented for counteracting some of the side effects of prolonged dialysis. An elegant method for Cr supplementation of this group of patients, undergoing either peritoneal or haemodialysis, would be to add appropriate amounts of Cr directly into the dialysis fluid. This would ease compliance and spare the patients to have to orally ingest yet another powder besides phosphate and calcium binders, etc. In the only study so with dialysis patients, involving the very limited number of five patients, oral Cr supplementation reduced spastic muscle cramps, a problem often observed in these patients (Chang et al. <xref ref-type="bibr" rid="CR34">2002</xref>).</p>
      </sec>
      <sec id="Sec30">
        <title>Creatine as feed additive for animal nutrition, growing life stock and aquaculture?</title>
        <p>Endogenous synthesis of Cr is energy-costly and consumes some 40% of the SAM available for methylation reactions (Brosnan et al. <xref ref-type="bibr" rid="CR24">2007a</xref>, <xref ref-type="bibr" rid="CR25">b</xref>, <xref ref-type="bibr" rid="CR26">2009</xref>). In addition, the three amino acids needed for Cr synthesis, arginine, glycine and methionine are valuable and some are &#x2018;physiologically&#x2019; expensive. By including chemically synthesised Cr in a pure form in animal feeds, these amino acids would be spared for protein synthesis and growth. This holds true also for processed and dry pet food, which compared with fresh meat and offal contains very little Cr (Harris et al. <xref ref-type="bibr" rid="CR72">1997</xref>), such that supplementation with Cr of pet food would make sense.</p>
        <p>Chickens fed during a growing period of 41&#xA0;days with an entirely vegetable soy-based feed, to which 0.2% w/w of pure Cr was added, show a 4% greater body weight gain compared with chickens fed with normal meat- and fish-meal containing feed. In addition, feed consumption in the Cr group decreased by 2&#x2013;3% and the weight gain was shown to be due to growth of lean muscle mass (Pfirter and Wallimann, unpublished data). Thus, Cr may have significant potential as an additive for animal feed, replacing millions of tons of meat- and fish-meal for animals, as well as for fish aquaculture. On a global scale, this could help with problems of world hunger and the prevention of over-fishing of oceans for fish-meal production. Interestingly Cr supplementation of <italic>Drosophila melanogaster</italic>, known to express arginine kinase (AK) instead of CK (Wallimann and Eppenberger <xref ref-type="bibr" rid="CR218">1973</xref>), protects these flies from oxidative stress caused by exposure to rotenone, a potent mitochondrial toxin, and paraquat, a potent herbicidal redox cycler, that both generate ROS (Hosamani et al. <xref ref-type="bibr" rid="CR81">2010</xref>). Since these insects are not able to phosphorylate Cr into PCr, the protective effects of Cr observed cannot be due to improved cellular energetics, but are more likely related to anti-oxidant and/or anti-apoptotic effects of this guanidino compound. Thus Cr may be added to animal feed as a protectant also against environmental oxidative and toxic stress.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <p content-type="acknowledgment">Work from the authors cited in this review has been supported by the Swiss National Science Foundation, ETH Z&#xFC;rich, French &#x201C;Agence Nationale de Recherche&#x201D; (&#x201C;chaire d&#x2019;excellence&#x201D; given to US), the University Joseph Fourier &#x201C;Fonds d&#x2019;intervention&#x201D;, an EC Marie Curie Intraeuropean Fellowship (ANTHRAWES contract 041870 to MTS), an EC Marie Curie Reintegration Grant (ANTHRAPLUS contract 249202 to MTS), and the Swiss foundations Z&#xFC;rcher Krebsliga, Zentralschweizer Krebsstiftung, and Wolfermann-N&#xE4;geli Stiftung. T. W. would like to thank Prof. emeritus Hans M. Eppenberger for the occasion to start these CK and Cr-related projects in his former laboratory and for support. We would like to dedicate this essay to all former members of the Wallimann and Schlattner research groups, who contributed over the past 30&#xA0;years in a significant way to elucidate the localization, structure, function and regulation of CK and the effects of Cr in vitro and in vivo. It is indeed very gratifying for basic researchers to see that some of the ideas on Cr supplementation are slowly finding their way into the clinics and that patients may benefit from a simple and safe intervention like Cr. We also express our gratitude to all external national and international collaborators, who often engaged in mutual long-term collaborations without many questions asked and to whom we developed personal friendships.</p>
      <p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Selivanov</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Hodgson</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Pucar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Zingman</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dzeja</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Alekseev</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Terzic</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Coupling of cell energetics with membrane metabolic sensing. Integrative signaling through creatine kinase phosphotransfer disrupted by M-CK gene knock-out</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>24427</fpage>
          <lpage>24434</lpage>
          <pub-id pub-id-type="pmid">11967264</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR2">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adcock</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Nedelcu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Loenneker</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>BP</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia</article-title>
          <source>Dev Neurosci</source>
          <year>2002</year>
          <volume>24</volume>
          <fpage>382</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="pmid">12640176</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR3">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Adhihetty</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases</article-title>
          <source>Neuromolecular Med</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>275</fpage>
          <lpage>290</lpage>
          <pub-id pub-id-type="pmid">19005780</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR4">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alfieri</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Bonelli</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Cavazzoni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brigotti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fumarola</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sestili</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mozzoni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Palma</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mutti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Carnicelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Vacondio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Borghetti</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Petronini</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress</article-title>
          <source>J Physiol</source>
          <year>2006</year>
          <volume>576</volume>
          <fpage>391</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">16873409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR5">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aloia</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Vaswani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Flaster</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Relationship of body water compartments to age, race, and fat-free mass</article-title>
          <source>J Lab Clin Med</source>
          <year>1998</year>
          <volume>132</volume>
          <fpage>483</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="pmid">9851738</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR6">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andres</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Ducray</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Perez-Bouza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Krebs</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system</article-title>
          <source>Cell Transplant</source>
          <year>2005</year>
          <volume>14</volume>
          <fpage>537</fpage>
          <lpage>550</lpage>
          <pub-id pub-id-type="pmid">16355565</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR7">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andres</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Perez-Bouza</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Krebs</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Seiler</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue</article-title>
          <source>Neuroscience</source>
          <year>2005</year>
          <volume>133</volume>
          <fpage>701</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="pmid">15890457</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR8">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andres</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Ducray</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>HR</given-names>
            </name>
          </person-group>
          <article-title>Functions and effects of creatine in the central nervous system</article-title>
          <source>Brain Res Bull</source>
          <year>2008</year>
          <volume>76</volume>
          <fpage>329</fpage>
          <lpage>343</lpage>
          <pub-id pub-id-type="pmid">18502307</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR9">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azzolin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Stockum</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Petronilli</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Forte</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bernardi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The mitochondrial permeability transition from yeast to mammals</article-title>
          <source>FEBS Lett</source>
          <year>2010</year>
          <volume>584</volume>
          <fpage>2504</fpage>
          <lpage>2509</lpage>
          <pub-id pub-id-type="pmid">20398660</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR10">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Targeting cellular energy production in neurological disorders</article-title>
          <source>Expert Opin Investig Drugs</source>
          <year>2003</year>
          <volume>12</volume>
          <fpage>1655</fpage>
          <lpage>1679</lpage>
          <pub-id pub-id-type="pmid">14519086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR11">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassit</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Curi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Costa Rosa</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation reduces plasma levels of pro-inflammatory cytokines and PGE2 after a half-ironman competition</article-title>
          <source>Amino Acids</source>
          <year>2008</year>
          <volume>35</volume>
          <fpage>425</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">17917696</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR12">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bender</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Beckers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Holter</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Haack</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ruthsatz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vogt-Weisenhorn</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Genius</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rujescu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Irmler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mijalski</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mader</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quintanilla-Martinez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gailus-Durner</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Angelis</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Wurst</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Klopstock</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine improves health and survival of mice</article-title>
          <source>Neurobiol Aging</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>1404</fpage>
          <lpage>1411</lpage>
          <pub-id pub-id-type="pmid">17416441</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR13">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bender</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Samtleben</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Elstner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Klopstock</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Long-term creatine supplementation is safe in aged patients with Parkinson disease</article-title>
          <source>Nutr Res</source>
          <year>2008</year>
          <volume>28</volume>
          <fpage>172</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">19083405</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR14">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berneburg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gremmel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kurten</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Schroeder</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hertel</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mikecz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Declercq</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Matsui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruzicka</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Krutmann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences</article-title>
          <source>J Invest Dermatol</source>
          <year>2005</year>
          <volume>125</volume>
          <fpage>213</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">16098029</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR15">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pomponi</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Kokuhuta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Iwasaki</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ellington</surname>
              <given-names>WR</given-names>
            </name>
          </person-group>
          <article-title>Origin of the genes for the isoforms of creatine kinase</article-title>
          <source>Gene</source>
          <year>2007</year>
          <volume>392</volume>
          <fpage>273</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">17329042</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR16">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bessman</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>The physiological significance of the creatine phosphate shuttle</article-title>
          <source>Adv Exp Med Biol</source>
          <year>1986</year>
          <volume>194</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="pmid">3529851</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR17">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bessman</surname>
              <given-names>SP</given-names>
            </name>
          </person-group>
          <article-title>The creatine phosphate energy shuttle&#x2013;the molecular asymmetry of a &#x201C;pool&#x201D;</article-title>
          <source>Anal Biochem</source>
          <year>1987</year>
          <volume>161</volume>
          <fpage>519</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="pmid">3578809</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR18">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bessman</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Transport of energy in muscle: the phosphorylcreatine shuttle</article-title>
          <source>Science</source>
          <year>1981</year>
          <volume>211</volume>
          <fpage>448</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">6450446</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR19">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bohnhorst</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Geuting</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Peter</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Dordelmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wilken</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Poets</surname>
              <given-names>CF</given-names>
            </name>
          </person-group>
          <article-title>Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity</article-title>
          <source>Pediatrics</source>
          <year>2004</year>
          <volume>113</volume>
          <fpage>e303</fpage>
          <lpage>e307</lpage>
          <pub-id pub-id-type="pmid">15060257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR20">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brdiczka</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Zorov</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Sheu</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial contact sites: their role in energy metabolism and apoptosis</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2006</year>
          <volume>1762</volume>
          <fpage>148</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">16324828</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR21">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brewer</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons</article-title>
          <source>J Neurochem</source>
          <year>2000</year>
          <volume>74</volume>
          <fpage>1968</fpage>
          <lpage>1978</lpage>
          <pub-id pub-id-type="pmid">10800940</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR22">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broadhurst</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Cunnane</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Rift Valley lake fish and shellfish provided brain-specific nutrition for early Homo</article-title>
          <source>Br J Nutr</source>
          <year>1998</year>
          <volume>79</volume>
          <fpage>3</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">9505798</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR23">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Creatine: endogenous metabolite, dietary, and therapeutic supplement</article-title>
          <source>Annu Rev Nutr</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>241</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="pmid">17430086</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR24">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Amino acids and the regulation of methyl balance in humans</article-title>
          <source>Curr Opin Clin Nutr Metab Care</source>
          <year>2007</year>
          <volume>10</volume>
          <fpage>52</fpage>
          <lpage>57</lpage>
          <pub-id pub-id-type="pmid">17143055</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR25">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Edison</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>New insights into creatine function and synthesis</article-title>
          <source>Adv Enzyme Regul</source>
          <year>2007</year>
          <volume>47</volume>
          <fpage>252</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">17335874</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR26">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Wijekoon</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Warford-Woolgar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Trottier</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Brunton</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bertolo</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance</article-title>
          <source>J Nutr</source>
          <year>2009</year>
          <volume>139</volume>
          <fpage>1292</fpage>
          <lpage>1297</lpage>
          <pub-id pub-id-type="pmid">19474158</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR27">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buford</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Kreider</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Spano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ziegenfuss</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Landis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Antonio</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>International Society of Sports Nutrition position stand: creatine supplementation and exercise</article-title>
          <source>J Int Soc Sports Nutr</source>
          <year>2007</year>
          <volume>4</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="pmid">17908288</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR28">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burke</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Chilibeck</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Parise</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Candow</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effect of creatine and weight training on muscle creatine and performance in vegetarians</article-title>
          <source>Med Sci Sports Exerc</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>1946</fpage>
          <lpage>1955</lpage>
          <pub-id pub-id-type="pmid">14600563</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR29">
        <mixed-citation publication-type="other">Cannata DJ, Ireland Z, Dickinson H, Snow RJ, Russell AP, West JM, Walker DW (2010) Maternal creatine supplementation from mid-pregnancy protects the newborn spiny mouse diaphragm from intrapartum hypoxia-induced damage. Pediatr Res 68:393&#x2013;398</mixed-citation>
      </ref>
      <ref id="CR30">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canonaco</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Pruett</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of phosphagen kinase systems confers resistance to transient stresses in Saccharomyces cerevisiae by buffering the ATP pool</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>31303</fpage>
          <lpage>31309</lpage>
          <pub-id pub-id-type="pmid">12036963</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR31">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canonaco</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sauer</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of arginine kinase improves recovery from pH stress of <italic>Escherichia coli</italic></article-title>
          <source>Biotechnol Lett</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>1013</fpage>
          <lpage>1017</lpage>
          <pub-id pub-id-type="pmid">12889807</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR32">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Kingston</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Docosahexaenoic acid, the aquatic diet, and hominin encephalization: difficulties in establishing evolutionary links</article-title>
          <source>Am J Hum Biol</source>
          <year>2007</year>
          <volume>19</volume>
          <fpage>132</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">17160979</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR33">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ceddia</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Sweeney</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells</article-title>
          <source>J Physiol</source>
          <year>2004</year>
          <volume>555</volume>
          <fpage>409</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="pmid">14724211</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR34">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Creatine monohydrate treatment alleviates muscle cramps associated with haemodialysis</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2002</year>
          <volume>17</volume>
          <fpage>1978</fpage>
          <lpage>1981</lpage>
          <pub-id pub-id-type="pmid">12401856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR35">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Ryu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Pak</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>ZH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption</article-title>
          <source>Nat Med</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>966</fpage>
          <lpage>972</lpage>
          <pub-id pub-id-type="pmid">18724377</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR36">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chilibeck</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Chrusch</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Chad</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Shawn Davison</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Creatine monohydrate and resistance training increase bone mineral content and density in older men</article-title>
          <source>J Nutr Health Aging</source>
          <year>2005</year>
          <volume>9</volume>
          <fpage>352</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="pmid">16222402</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR37">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sharman</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Carlsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jue</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Metabolic fluctuation during a muscle contraction cycle</article-title>
          <source>Am J Physiol</source>
          <year>1998</year>
          <volume>274</volume>
          <fpage>C846</fpage>
          <lpage>C852</lpage>
          <pub-id pub-id-type="pmid">9530118</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR38">
        <mixed-citation publication-type="other">Clark JF (1994) The creatine kinase system in smooth muscle. Mol Cell Biochem 133&#x2013;134:221&#x2013;232</mixed-citation>
      </ref>
      <ref id="CR39">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Khuchua</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kuznetsov</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Compartmentation of creatine kinase isoenzymes in myometrium of gravid guinea-pig</article-title>
          <source>J Physiol</source>
          <year>1993</year>
          <volume>466</volume>
          <fpage>553</fpage>
          <lpage>572</lpage>
          <pub-id pub-id-type="pmid">8410707</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR40">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dalbo</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Lockwood</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Tucker</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Kreider</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Kerksick</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults</article-title>
          <source>Dyn Med</source>
          <year>2009</year>
          <volume>8</volume>
          <fpage>6</fpage>
          <pub-id pub-id-type="pmid">20034396</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR41">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wray</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The effects of pregnancy and parturition on phosphorus metabolites in rat uterus studied by 31P nuclear magnetic resonance</article-title>
          <source>J Physiol</source>
          <year>1985</year>
          <volume>368</volume>
          <fpage>19</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">4078741</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR42">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groof</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>FT</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Changes in glycolytic network and mitochondrial design in creatine kinase-deficient muscles</article-title>
          <source>Muscle Nerve</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>1188</fpage>
          <lpage>1196</lpage>
          <pub-id pub-id-type="pmid">11494272</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR43">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groof</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Smeets</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Groot Koerkamp</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Mul</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Tabak</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles</article-title>
          <source>FEBS Lett</source>
          <year>2001</year>
          <volume>506</volume>
          <fpage>73</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">11591374</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR44">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groof</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Errington</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Willems</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Koopman</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>The creatine kinase system is essential for optimal refill of the sarcoplasmic reticulum Ca2+ store in skeletal muscle</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>5275</fpage>
          <lpage>5284</lpage>
          <pub-id pub-id-type="pmid">11734556</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR45">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deldicque</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Theisen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bertrand</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hespel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hue</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Francaux</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2007</year>
          <volume>293</volume>
          <fpage>C1263</fpage>
          <lpage>C1271</lpage>
          <pub-id pub-id-type="pmid">17652429</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR46">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deldicque</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Atherton</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Theisen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nielens</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rennie</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Francaux</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle</article-title>
          <source>J Appl Physiol</source>
          <year>2008</year>
          <volume>104</volume>
          <fpage>371</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">18048590</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR47">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deminice</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Portari</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>Vannucchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jordao</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats</article-title>
          <source>Br J Nutr</source>
          <year>2009</year>
          <volume>102</volume>
          <fpage>110</fpage>
          <lpage>116</lpage>
          <pub-id pub-id-type="pmid">19079843</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR48">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dillon</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>The theory of diazymes and functional coupling of pyruvate kinase and creatine kinase</article-title>
          <source>J Theor Biol</source>
          <year>1990</year>
          <volume>143</volume>
          <fpage>275</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">2385106</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR49">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Walzel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Speer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>17760</fpage>
          <lpage>17766</lpage>
          <pub-id pub-id-type="pmid">12621025</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR50">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dzeja</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Terzic</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels</article-title>
          <source>FASEB J</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>523</fpage>
          <lpage>529</lpage>
          <pub-id pub-id-type="pmid">9576479</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR51">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kabsch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fritz-Wolf</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of brain-type creatine kinase at 1.41 A resolution</article-title>
          <source>Protein Sci</source>
          <year>1999</year>
          <volume>8</volume>
          <fpage>2258</fpage>
          <lpage>2269</lpage>
          <pub-id pub-id-type="pmid">10595529</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR52">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fritz-Wolf</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kabsch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of human ubiquitous mitochondrial creatine kinase</article-title>
          <source>Proteins</source>
          <year>2000</year>
          <volume>39</volume>
          <fpage>216</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">10737943</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR53">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stolz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>A conserved negatively charged cluster in the active site of creatine kinase is critical for enzymatic activity</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>27094</fpage>
          <lpage>27099</lpage>
          <pub-id pub-id-type="pmid">10829032</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR54">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Epand</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lacombe</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Epand</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Novel lipid transfer property of two mitochondrial proteins that bridge the inner and outer membranes</article-title>
          <source>Biophys J</source>
          <year>2007</year>
          <volume>92</volume>
          <fpage>126</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">17028143</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR55">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Epand</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Epand</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Cardiolipin clusters and membrane domain formation induced by mitochondrial proteins</article-title>
          <source>J Mol Biol</source>
          <year>2007</year>
          <volume>365</volume>
          <fpage>968</fpage>
          <lpage>980</lpage>
          <pub-id pub-id-type="pmid">17097675</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR56">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eppenberger-Eberhardt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Riesinger</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Messerli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schwarb</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Adult rat cardiomyocytes cultured in creatine-deficient medium display large mitochondria with paracrystalline inclusions, enriched for creatine kinase</article-title>
          <source>J Cell Biol</source>
          <year>1991</year>
          <volume>113</volume>
          <fpage>289</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="pmid">1849138</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR57">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francaux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Poortmans</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Side effects of creatine supplementation in athletes</article-title>
          <source>Int J Sports Physiol Perform</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>311</fpage>
          <lpage>323</lpage>
          <pub-id pub-id-type="pmid">19124889</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR58">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fritz-Wolf</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schnyder</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kabsch</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Structure of mitochondrial creatine kinase</article-title>
          <source>Nature</source>
          <year>1996</year>
          <volume>381</volume>
          <fpage>341</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="pmid">8692275</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR59">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerber</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>ap Gwynn</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Alini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Stimulatory effects of creatine on metabolic activity, differentiation and mineralization of primary osteoblast-like cells in monolayer and micromass cell cultures</article-title>
          <source>Eur Cell Mater</source>
          <year>2005</year>
          <volume>10</volume>
          <fpage>8</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="pmid">16025431</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR60">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerber</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gerber</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dora</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Uebelhart</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation stimulates collagen type I and osteoprotegerin secretion of healthy and osteopenic primary human osteoblast-like cells in vitro</article-title>
          <source>Bone</source>
          <year>2008</year>
          <volume>42</volume>
          <fpage>S21</fpage>
        </mixed-citation>
      </ref>
      <ref id="CR61">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gotshalk</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Volek</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Staron</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Denegar</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Hagerman</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Kraemer</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation improves muscular performance in older men</article-title>
          <source>Med Sci Sports Exerc</source>
          <year>2002</year>
          <volume>34</volume>
          <fpage>537</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="pmid">11880821</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR62">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gotshalk</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Kraemer</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Mendonca</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Vingren</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Spiering</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Hatfield</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Fragala</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Volek</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation improves muscular performance in older women</article-title>
          <source>Eur J Appl Physiol</source>
          <year>2008</year>
          <volume>102</volume>
          <fpage>223</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="pmid">17943308</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR63">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenhaff</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Casey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Short</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Soderlund</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hultman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man</article-title>
          <source>Clin Sci (Lond)</source>
          <year>1993</year>
          <volume>84</volume>
          <fpage>565</fpage>
          <lpage>571</lpage>
          <pub-id pub-id-type="pmid">8504634</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR64">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grehl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vorgerd</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tegenthoff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Malin</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Zange</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Impaired aerobic glycolysis in muscle phosphofructokinase deficiency results in biphasic post-exercise phosphocreatine recovery in 31P magnetic resonance spectroscopy</article-title>
          <source>Neuromuscul Disord</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>480</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="pmid">9829278</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR65">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gualano</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Novaes</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Artioli</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Freire</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Scagliusi</surname>
              <given-names>FB</given-names>
            </name>
            <name>
              <surname>Rogeri</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Roschel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ugrinowitsch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lancha</surname>
              <given-names>AH</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training</article-title>
          <source>Amino Acids</source>
          <year>2008</year>
          <volume>34</volume>
          <fpage>245</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">17396216</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR66">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gualano</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ugrinowitsch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Novaes</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Artioli</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Seguro</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Lancha</surname>
              <given-names>AH</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Effects of creatine supplementation on renal function: a randomized, double-blind, placebo-controlled clinical trial</article-title>
          <source>Eur J Appl Physiol</source>
          <year>2008</year>
          <volume>103</volume>
          <fpage>33</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">18188581</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR67">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gualano</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Sapienza</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Seguro</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Lancha</surname>
              <given-names>AH</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Effect of short-term high-dose creatine supplementation on measured GFR in a young man with a single kidney</article-title>
          <source>Am J Kidney Dis</source>
          <year>2010</year>
          <volume>55</volume>
          <fpage>e7</fpage>
          <lpage>e9</lpage>
          <pub-id pub-id-type="pmid">20060630</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR68">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guerrero</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Beron</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Spindler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Groscurth</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Verrey</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Metabolic support of Na+ pump in apically permeabilized A6 kidney cell epithelia: role of creatine kinase</article-title>
          <source>Am J Physiol</source>
          <year>1997</year>
          <volume>272</volume>
          <fpage>C697</fpage>
          <lpage>C706</lpage>
          <pub-id pub-id-type="pmid">9124314</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR69">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guidi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Potenza</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sestili</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guescini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stocchi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zeppa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Polidori</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Annibalini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Stocchi</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2008</year>
          <volume>1780</volume>
          <fpage>16</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">18022765</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR70">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hadjicharalambous</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kilduff</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Pitsiladis</surname>
              <given-names>YP</given-names>
            </name>
          </person-group>
          <article-title>Brain serotonin and dopamine modulators, perceptual responses and endurance performance during exercise in the heat following creatine supplementation</article-title>
          <source>J Int Soc Sports Nutr</source>
          <year>2008</year>
          <volume>5</volume>
          <fpage>14</fpage>
          <pub-id pub-id-type="pmid">18826587</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR71">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Soderlund</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hultman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation</article-title>
          <source>Clin Sci (Lond)</source>
          <year>1992</year>
          <volume>83</volume>
          <fpage>367</fpage>
          <lpage>374</lpage>
          <pub-id pub-id-type="pmid">1327657</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR72">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Warnes</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Orme</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>The concentration of creatine in meat, offal and commercial dog food</article-title>
          <source>Res Vet Sci</source>
          <year>1997</year>
          <volume>62</volume>
          <fpage>58</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">9160426</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR73">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hatano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kitai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsunekawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Inomoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shinohara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chance</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yamaoka</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase</article-title>
          <source>Hepatology</source>
          <year>1996</year>
          <volume>24</volume>
          <fpage>663</fpage>
          <lpage>669</lpage>
          <pub-id pub-id-type="pmid">8781340</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR74">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hatano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kanazawa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tsuyuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tsunekawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Iwata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chance</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Yamaoka</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase</article-title>
          <source>Liver Int</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>384</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">15287863</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR75">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hausmann</surname>
              <given-names>ON</given-names>
            </name>
            <name>
              <surname>Fouad</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Protective effects of oral creatine supplementation on spinal cord injury in rats</article-title>
          <source>Spinal Cord</source>
          <year>2002</year>
          <volume>40</volume>
          <fpage>449</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">12185606</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR76">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hemmer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Riesinger</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Quest</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Brain-type creatine kinase in photoreceptor cell outer segments: role of a phosphocreatine circuit in outer segment energy metabolism and phototransduction</article-title>
          <source>J Cell Sci</source>
          <year>1993</year>
          <volume>106</volume>
          <issue>Pt 2</issue>
          <fpage>671</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="pmid">8282772</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR77">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hespel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Derave</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Ergogenic effects of creatine in sports and rehabilitation</article-title>
          <source>Subcell Biochem</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>245</fpage>
          <lpage>259</lpage>
          <pub-id pub-id-type="pmid">18652080</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR78">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hespel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Op&#x2019;t Eijnde</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Leemputte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Urso</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Greenhaff</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Labarque</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dymarkowski</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hecke</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans</article-title>
          <source>J Physiol</source>
          <year>2001</year>
          <volume>536</volume>
          <fpage>625</fpage>
          <lpage>633</lpage>
          <pub-id pub-id-type="pmid">11600695</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR79">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hornemann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stolz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Isoenzyme-specific interaction of muscle-type creatine kinase with the sarcomeric M-line is mediated by NH(2)-terminal lysine charge-clamps</article-title>
          <source>J Cell Biol</source>
          <year>2000</year>
          <volume>149</volume>
          <fpage>1225</fpage>
          <lpage>1234</lpage>
          <pub-id pub-id-type="pmid">10851020</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR80">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hornemann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kempa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Himmel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hayess</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Furst</surname>
              <given-names>DO</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Muscle-type creatine kinase interacts with central domains of the M-band proteins myomesin and M-protein</article-title>
          <source>J Mol Biol</source>
          <year>2003</year>
          <volume>332</volume>
          <fpage>877</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="pmid">12972258</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR81">
        <mixed-citation publication-type="other">Hosamani R, Ramesh SR, Muralidhara (2010) Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine. Neurochem Res 35:1402&#x2013;1412</mixed-citation>
      </ref>
      <ref id="CR82">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Furihata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ito-Ishida</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaminogawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tanokura</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Nondestructive observation of bovine milk by NMR spectroscopy: analysis of existing States of compounds and detection of new compounds</article-title>
          <source>J Agric Food Chem</source>
          <year>2004</year>
          <volume>52</volume>
          <fpage>4969</fpage>
          <lpage>4974</lpage>
          <pub-id pub-id-type="pmid">15291460</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR83">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hulsemann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Manz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wember</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schoch</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Administration of creatine and creatinine with breast milk and infant milk preparations</article-title>
          <source>Klin Padiatr</source>
          <year>1987</year>
          <volume>199</volume>
          <fpage>292</fpage>
          <lpage>295</lpage>
          <pub-id pub-id-type="pmid">3657037</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR84">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurtley</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Spatial cell biology. Location, location, location. Introduction</article-title>
          <source>Science</source>
          <year>2009</year>
          <volume>326</volume>
          <fpage>1205</fpage>
          <pub-id pub-id-type="pmid">19965460</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR85">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>In &#x2018;t Zandt</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Renema</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Klomp</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study</article-title>
          <source>J Neurochem</source>
          <year>2004</year>
          <volume>90</volume>
          <fpage>1321</fpage>
          <lpage>1330</lpage>
          <pub-id pub-id-type="pmid">15341516</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR86">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ireland</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dickinson</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (<italic>Acomys cahirinus</italic>)?</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>2008</year>
          <volume>198</volume>
          <issue>431</issue>
          <fpage>e431</fpage>
          <lpage>e436</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR87">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ireland</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse</article-title>
          <source>BMC Dev Biol</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>39</fpage>
          <pub-id pub-id-type="pmid">19570237</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR88">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnston</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>MacNeil</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Candow</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance</article-title>
          <source>J Strength Cond Res</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>116</fpage>
          <lpage>120</lpage>
          <pub-id pub-id-type="pmid">19130643</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR89">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jost</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>In &#x2018;t Zandt</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Verheij</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cools</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, mossy fibre field size and determination of seizure susceptibility</article-title>
          <source>Eur J Neurosci</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>1692</fpage>
          <lpage>1706</lpage>
          <pub-id pub-id-type="pmid">12059977</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR90">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaasik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Veksler</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Boehm</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Novotova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>From energy store to energy flux: a study in creatine kinase-deficient fast skeletal muscle</article-title>
          <source>FASEB J</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>708</fpage>
          <lpage>710</lpage>
          <pub-id pub-id-type="pmid">12586739</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR91">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaldis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hemmer</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zanolla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Holtzman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>&#x2018;Hot spots&#x2019; of creatine kinase localization in brain: cerebellum, hippocampus and choroid plexus</article-title>
          <source>Dev Neurosci</source>
          <year>1996</year>
          <volume>18</volume>
          <fpage>542</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="pmid">8940630</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR92">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaldis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stolz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zanolla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rothen-Rutishauser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vorherr</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Identification of two distinctly localized mitochondrial creatine kinase isoenzymes in spermatozoa</article-title>
          <source>J Cell Sci</source>
          <year>1996</year>
          <volume>109</volume>
          <issue>Pt 8</issue>
          <fpage>2079</fpage>
          <lpage>2088</lpage>
          <pub-id pub-id-type="pmid">8856504</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR93">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaldis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kamp</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piendl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Functions of creatine kinase isoenzymes in spermatozoa</article-title>
          <source>Adv Dev Biochem</source>
          <year>1997</year>
          <volume>5</volume>
          <fpage>275</fpage>
          <lpage>312</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR94">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamber</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koster</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kreis</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Boesch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hoppeler</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation&#x2013;part I: performance, clinical chemistry, and muscle volume</article-title>
          <source>Med Sci Sports Exerc</source>
          <year>1999</year>
          <volume>31</volume>
          <fpage>1763</fpage>
          <lpage>1769</lpage>
          <pub-id pub-id-type="pmid">10613426</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR95">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kay</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Direct evidence for the control of mitochondrial respiration by mitochondrial creatine kinase in oxidative muscle cells in situ</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>6937</fpage>
          <lpage>6944</lpage>
          <pub-id pub-id-type="pmid">10702255</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR96">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kennaugh</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Arthur</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hartmann</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The concentration of creatine and creatine phosphate in sow colostrum and milk throughout lactation and weaning</article-title>
          <source>Aust J Agric Res</source>
          <year>1997</year>
          <volume>48</volume>
          <fpage>1105</fpage>
          <lpage>1111</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR97">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerksick</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stout</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wilborn</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kreider</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kalman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ziegenfuss</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Landis</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ivy</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Antonio</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>International Society of Sports Nutrition position stand: nutrient timing</article-title>
          <source>J Int Soc Sports Nutr</source>
          <year>2008</year>
          <volume>5</volume>
          <fpage>17</fpage>
          <pub-id pub-id-type="pmid">18834505</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR98">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klivenyi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Bogdanov</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Andreassen</surname>
              <given-names>OA</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wermer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaddurah-Daouk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis</article-title>
          <source>Nat Med</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>347</fpage>
          <lpage>350</lpage>
          <pub-id pub-id-type="pmid">10086395</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR99">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kottke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nalam</surname>
              <given-names>VK</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Location and regulation of octameric mitochondrial creatine kinase in the contact sites</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1991</year>
          <volume>1061</volume>
          <fpage>215</fpage>
          <lpage>225</lpage>
          <pub-id pub-id-type="pmid">1998693</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR100">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraemer</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Volek</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation. Its role in human performance</article-title>
          <source>Clin Sports Med</source>
          <year>1999</year>
          <volume>18</volume>
          <fpage>651</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">10410847</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR101">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kraft</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hornemann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stolz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nier</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Coupling of creatine kinase to glycolytic enzymes at the sarcomeric I-band of skeletal muscle: a biochemical study in situ</article-title>
          <source>J Muscle Res Cell Motil</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>691</fpage>
          <lpage>703</lpage>
          <pub-id pub-id-type="pmid">11227796</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR102">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreider</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Melton</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rasmussen</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lancaster</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cantler</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Milnor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Almada</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Long-term creatine supplementation does not significantly affect clinical markers of health in athletes</article-title>
          <source>Mol Cell Biochem</source>
          <year>2003</year>
          <volume>244</volume>
          <fpage>95</fpage>
          <lpage>104</lpage>
          <pub-id pub-id-type="pmid">12701816</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR103">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kroemer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Galluzzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Brenner</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial membrane permeabilization in cell death</article-title>
          <source>Physiol Rev</source>
          <year>2007</year>
          <volume>87</volume>
          <fpage>99</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">17237344</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR104">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuiper</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Pluk</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Leeuwen</surname>
              <given-names>FN</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase-mediated ATP supply fuels actin-based events in phagocytosis</article-title>
          <source>PLoS Biol</source>
          <year>2008</year>
          <volume>6</volume>
          <fpage>e51</fpage>
          <pub-id pub-id-type="pmid">18336068</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR105">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuiper</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Horssen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Dommelen</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>te Lindert</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>ten Hagen</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Janssen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Local ATP generation by brain-type creatine kinase (CK-B) facilitates cell motility</article-title>
          <source>PLoS One</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>e5030</fpage>
          <pub-id pub-id-type="pmid">19333390</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR106">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kumar</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Studies in human myometrium during pregnancy. III. Distribution of high phosphate compounds (adenosinetriphosphate and phosphocreatine)</article-title>
          <source>Am J Obstet Gynecol</source>
          <year>1962</year>
          <volume>84</volume>
          <fpage>586</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="pmid">14460494</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR107">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamarre</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Edison</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Wijekoon</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
          </person-group>
          <article-title>Suckling rat pups accumulate creatine primarily via de novo synthesis rather than from dam milk</article-title>
          <source>J Nutr</source>
          <year>2010</year>
          <volume>140</volume>
          <fpage>1570</fpage>
          <lpage>1573</lpage>
          <pub-id pub-id-type="pmid">20660282</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR108">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lawler</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Demaree</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Direct antioxidant properties of creatine</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2002</year>
          <volume>290</volume>
          <fpage>47</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">11779131</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR109">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lenz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Welge</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Elsasser</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Wittern</surname>
              <given-names>KP</given-names>
            </name>
            <name>
              <surname>Wenck</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stab</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Blatt</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The creatine kinase system in human skin: protective effects of creatine against oxidative and UV damage in vitro and in vivo</article-title>
          <source>J Invest Dermatol</source>
          <year>2005</year>
          <volume>124</volume>
          <fpage>443</fpage>
          <lpage>452</lpage>
          <pub-id pub-id-type="pmid">15675966</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR110">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Thali</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Smolak</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Alzamora</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pastor-Soler</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hallows</surname>
              <given-names>KR</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the creatine transporter by AMP-activated protein kinase in kidney epithelial cells</article-title>
          <source>Am J Physiol Renal Physiol</source>
          <year>2010</year>
          <volume>299</volume>
          <fpage>F167</fpage>
          <lpage>F177</lpage>
          <pub-id pub-id-type="pmid">20462973</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR111">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Linton</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Holzhausen</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Babai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyagishima</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Stearns</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chertov</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Caffe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pluk</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Seeliger</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Tanimoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fong</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bolton</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kuok</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Sweet</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Bartoletti</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Radu</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Zagotta</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Townes-Anderson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Sampath</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Sokolov</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thoreson</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Hurley</surname>
              <given-names>JB</given-names>
            </name>
          </person-group>
          <article-title>Flow of energy in the outer retina in darkness and in light</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>8599</fpage>
          <lpage>8604</lpage>
          <pub-id pub-id-type="pmid">20445106</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR112">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Louis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beneden</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dehoux</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Thissen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Francaux</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Creatine increases IGF-I and myogenic regulatory factor mRNA in C(2)C(12) cells</article-title>
          <source>FEBS Lett</source>
          <year>2004</year>
          <volume>557</volume>
          <fpage>243</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">14741375</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR113">
        <mixed-citation publication-type="other">Maniti O, Lecompte MF, Marcillat O, Vial C, Granjon T (2010) Mitochondrial creatine kinase interaction with cardiolipin-containing biomimetic membranes is a two-step process involving adsorption and insertion. Eur Biophys J 39:1649&#x2013;1655</mixed-citation>
      </ref>
      <ref id="CR114">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthews</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jenkins</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Ferrante</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Kaddurah-Daouk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington&#x2019;s disease</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>156</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="pmid">9412496</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR115">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McLeish</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Kenyon</surname>
              <given-names>GL</given-names>
            </name>
          </person-group>
          <article-title>Relating structure to mechanism in creatine kinase</article-title>
          <source>Crit Rev Biochem Mol Biol</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>1</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="pmid">15804623</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR116">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMorris</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mielcarz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Swain</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation and cognitive performance in elderly individuals</article-title>
          <source>Neuropsychol Dev Cogn B Aging Neuropsychol Cogn</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>517</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="pmid">17828627</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR117">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPherron</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Alemseged</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Marean</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Wynn</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Geraads</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bobe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bearat</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Evidence for stone-tool-assisted consumption of animal tissues before 3.39 million years ago at Dikika, Ethiopia</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>466</volume>
          <fpage>857</fpage>
          <lpage>860</lpage>
          <pub-id pub-id-type="pmid">20703305</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR118">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mekhfi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hoerter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lauer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wisnewsky</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue</article-title>
          <source>Am J Physiol</source>
          <year>1990</year>
          <volume>258</volume>
          <fpage>H1151</fpage>
          <lpage>H1158</lpage>
          <pub-id pub-id-type="pmid">2184680</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR119">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellanby</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>The metabolism of lactating women</article-title>
          <source>Proc Royal Soc Series B</source>
          <year>1913</year>
          <volume>86</volume>
          <fpage>88</fpage>
          <lpage>109</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR120">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meyer</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Santiago</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>da-Silva</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Felice</surname>
              <given-names>FG</given-names>
            </name>
            <name>
              <surname>Holub</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Galina</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinases-dependent ADP re-cycling activity</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>37361</fpage>
          <lpage>37371</lpage>
          <pub-id pub-id-type="pmid">17028195</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR121">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Halow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koretsky</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia</article-title>
          <source>Am J Physiol</source>
          <year>1993</year>
          <volume>265</volume>
          <fpage>C1544</fpage>
          <lpage>C1551</lpage>
          <pub-id pub-id-type="pmid">8279516</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR122">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milton</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The critical role played by animal source foods in human (Homo) evolution</article-title>
          <source>J Nutr</source>
          <year>2003</year>
          <volume>133</volume>
          <fpage>3886S</fpage>
          <lpage>3892S</lpage>
          <pub-id pub-id-type="pmid">14672286</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR123">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minami</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Schacht</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Creatine and tempol attenuate noise-induced hearing loss</article-title>
          <source>Brain Res</source>
          <year>2007</year>
          <volume>1148</volume>
          <fpage>83</fpage>
          <lpage>89</lpage>
          <pub-id pub-id-type="pmid">17359945</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR124">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morley</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Argiles</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Bhasin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cella</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Deutz</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Doehner</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Fearon</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Ferrucci</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hellerstein</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Kalantar-Zadeh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lochs</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mulligan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Muscaritoli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ponikowski</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Posthauer</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Rossi Fanelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Schambelan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schols</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Schuster</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Anker</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Nutritional recommendations for the management of sarcopenia</article-title>
          <source>J Am Med Dir Assoc</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>391</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="pmid">20627179</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR125">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mudd</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Brosnan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Jacobs</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Stabler</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Vance</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Methyl balance and transmethylation fluxes in humans</article-title>
          <source>Am J Clin Nutr</source>
          <year>2007</year>
          <volume>85</volume>
          <fpage>19</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">17209172</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR126">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newmeyer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cecil</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Schapiro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Degrauw</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title>Incidence of brain creatine transporter deficiency in males with developmental delay referred for brain magnetic resonance imaging</article-title>
          <source>J Dev Behav Pediatr</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>276</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">16100500</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR127">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Novotova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pavlovicova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Veksler</surname>
              <given-names>VI</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zahradnik</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructural remodeling of fast skeletal muscle fibers induced by invalidation of creatine kinase</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>C1279</fpage>
          <lpage>C1285</lpage>
          <pub-id pub-id-type="pmid">16855221</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR128">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Gorman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Beutner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1996</year>
          <volume>1276</volume>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="pmid">8816948</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR129">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Gorman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Beutner</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koretsky</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The role of creatine kinase in inhibition of mitochondrial permeability transition</article-title>
          <source>FEBS Lett</source>
          <year>1997</year>
          <volume>414</volume>
          <fpage>253</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">9315696</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR130">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Gorman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Piendl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics</article-title>
          <source>Mol Cell Biochem</source>
          <year>1997</year>
          <volume>174</volume>
          <fpage>283</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">9309701</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR131">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogimoto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Sakurada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Imamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kuboshima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Maeba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Owada</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis</article-title>
          <source>Mol Cell Biochem</source>
          <year>2003</year>
          <volume>244</volume>
          <fpage>135</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">12701822</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR132">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pastoris</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Aquilani</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Foppa</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bovio</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Segagni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baiardi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Catapano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Maccario</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Salvadeo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dossena</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Altered muscle energy metabolism in post-absorptive patients with chronic renal failure</article-title>
          <source>Scand J Urol Nephrol</source>
          <year>1997</year>
          <volume>31</volume>
          <fpage>281</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="pmid">9249894</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR133">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peral</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Galvez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soria</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Ilundain</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Developmental decrease in rat small intestinal creatine uptake</article-title>
          <source>Mech Ageing Dev</source>
          <year>2005</year>
          <volume>126</volume>
          <fpage>523</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">15722111</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR134">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Persky</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Rawson</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Safety of creatine supplementation</article-title>
          <source>Subcell Biochem</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>275</fpage>
          <lpage>289</lpage>
          <pub-id pub-id-type="pmid">18652082</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR135">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pischel</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Gastner</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine&#x2013;its chemical synthesis, chemistry, and legal status</article-title>
          <source>Subcell Biochem</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>291</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">18652083</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR136">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prass</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Royl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lindauer</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Freyer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Megow</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dirnagl</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Stockler-Ipsiroglu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Priller</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Improved reperfusion and neuroprotection by creatine in a mouse model of stroke</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>452</fpage>
          <lpage>459</lpage>
          <pub-id pub-id-type="pmid">16773141</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR137">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pulido</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Passaquin</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Leijendekker</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Challet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ruegg</surname>
              <given-names>UT</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>439</volume>
          <fpage>357</fpage>
          <lpage>362</lpage>
          <pub-id pub-id-type="pmid">9845353</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR138">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quest</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>McIlhinney</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Myristoylated and nonmyristoylated pools of sea urchin sperm flagellar creatine kinase exist side-by-side: myristoylation is necessary for efficient lipid association</article-title>
          <source>Biochemistry</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>6993</fpage>
          <lpage>7002</lpage>
          <pub-id pub-id-type="pmid">9188696</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR139">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quistorff</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Johansen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sahlin</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery</article-title>
          <source>Biochem J</source>
          <year>1993</year>
          <volume>291</volume>
          <issue>Pt 3</issue>
          <fpage>681</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">8489495</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR140">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rae</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Digney</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>McEwan</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Bates</surname>
              <given-names>TC</given-names>
            </name>
          </person-group>
          <article-title>Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial</article-title>
          <source>Proc Biol Sci</source>
          <year>2003</year>
          <volume>270</volume>
          <fpage>2147</fpage>
          <lpage>2150</lpage>
          <pub-id pub-id-type="pmid">14561278</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR141">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rao</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Bujacz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wlodawer</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Crystal structure of rabbit muscle creatine kinase</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>439</volume>
          <fpage>133</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">9849893</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR142">
        <mixed-citation publication-type="other">Rawson ES, Stec MJ, Frederickson SJ, Miles MP (2011) Low-dose creatine supplementation enhances fatigue resistance in the absence of weight gain. Nutrition 27:451&#x2013;455</mixed-citation>
      </ref>
      <ref id="CR143">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richards</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>A brief review of the archaeological evidence for Palaeolithic and Neolithic subsistence</article-title>
          <source>Eur J Clin Nutr</source>
          <year>2002</year>
          <volume>56</volume>
          <fpage>16</fpage>
          <pub-id pub-id-type="pmid">12494313</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR144">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Mahoney</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Parise</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders</article-title>
          <source>Muscle Nerve</source>
          <year>2007</year>
          <volume>35</volume>
          <fpage>235</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">17080429</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR145">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rojo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hovius</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Demel</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial creatine kinase mediates contact formation between mitochondrial membranes</article-title>
          <source>J Biol Chem</source>
          <year>1991</year>
          <volume>266</volume>
          <fpage>20290</fpage>
          <lpage>20295</lpage>
          <pub-id pub-id-type="pmid">1939087</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR146">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Volpe</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cotrufo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Muscle-type MM creatine kinase is specifically bound to sarcoplasmic reticulum and can support Ca2+ uptake and regulate local ATP/ADP ratios</article-title>
          <source>J Biol Chem</source>
          <year>1990</year>
          <volume>265</volume>
          <fpage>5258</fpage>
          <lpage>5266</lpage>
          <pub-id pub-id-type="pmid">2318892</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR147">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rostovtseva</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Sheldon</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Hassanzadeh</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Monge</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Bezrukov</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sackett</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2008</year>
          <volume>105</volume>
          <fpage>18746</fpage>
          <lpage>18751</lpage>
          <pub-id pub-id-type="pmid">19033201</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR148">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Safdar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yardley</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Melov</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation</article-title>
          <source>Physiol Genomics</source>
          <year>2008</year>
          <volume>32</volume>
          <fpage>219</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="pmid">17957000</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR149">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakellaris</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kotsiou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tamiolaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kalostos</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tsapaki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spanaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Spilioti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Charissis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Evangeliou</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study</article-title>
          <source>J Trauma</source>
          <year>2006</year>
          <volume>61</volume>
          <fpage>322</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="pmid">16917445</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR150">
        <mixed-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <source>Molecular systems bioenergetics: energy for life</source>
          <year>2007</year>
          <publisher-loc>Weinheim</publisher-loc>
          <publisher-name>Wiley</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="CR151">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Rosenshtraukh</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Smirnov</surname>
              <given-names>VN</given-names>
            </name>
            <name>
              <surname>Chazov</surname>
              <given-names>EI</given-names>
            </name>
          </person-group>
          <article-title>Role of creatine phosphokinase in cellular function and metabolism</article-title>
          <source>Can J Physiol Pharmacol</source>
          <year>1978</year>
          <volume>56</volume>
          <fpage>691</fpage>
          <lpage>706</lpage>
          <pub-id pub-id-type="pmid">361188</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR152">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Huchua</surname>
              <given-names>ZA</given-names>
            </name>
            <name>
              <surname>Preobrazhensky</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Emelin</surname>
              <given-names>IV</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase in regulation of heart function and metabolism. I. Further evidence for compartmentation of adenine nucleotides in cardiac myofibrillar and sarcolemmal coupled ATPase-creatine kinase systems</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1984</year>
          <volume>803</volume>
          <fpage>254</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">6231056</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR153">
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Stepanov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Jaliashvili</surname>
              <given-names>IV</given-names>
            </name>
            <name>
              <surname>Konorev</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kryzkanovsky</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Strumia</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Conway</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Molecular and cellular mechanisms of action for the cardioprotective and therapeutic role of creatine phosphate</article-title>
          <source>Creatine and creatine phosphate: scientific and clinical perspectives</source>
          <year>1996</year>
          <publisher-loc>San Diego</publisher-loc>
          <publisher-name>Academic Press</publisher-name>
          <fpage>91</fpage>
          <lpage>114</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR154">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Kongas</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Vendelin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Role of the creatine/phosphocreatine system in the regulation of mitochondrial respiration</article-title>
          <source>Acta Physiol Scand</source>
          <year>2000</year>
          <volume>168</volume>
          <fpage>635</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="pmid">10759600</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR155">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dzeja</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Vendelin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Terzic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Cardiac system bioenergetics: metabolic basis of the Frank-Starling law</article-title>
          <source>J Physiol</source>
          <year>2006</year>
          <volume>571</volume>
          <fpage>253</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="pmid">16410283</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR156">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Favier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guzun</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Molecular system bioenergetics: regulation of substrate supply in response to heart energy demands</article-title>
          <source>J Physiol</source>
          <year>2006</year>
          <volume>577</volume>
          <fpage>769</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="pmid">17008367</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR157">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Bassit</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Caperuto</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Costa Rosa</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>The effect of creatine supplementation upon inflammatory and muscle soreness markers after a 30&#xA0;km race</article-title>
          <source>Life Sci</source>
          <year>2004</year>
          <volume>75</volume>
          <fpage>1917</fpage>
          <lpage>1924</lpage>
          <pub-id pub-id-type="pmid">15306159</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR158">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Batista</surname>
              <given-names>ML</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Caperuto</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Costa Rosa</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after Doxorubicin treatment in rats</article-title>
          <source>Clin Exp Pharmacol Physiol</source>
          <year>2007</year>
          <volume>34</volume>
          <fpage>1294</fpage>
          <lpage>1299</lpage>
          <pub-id pub-id-type="pmid">17973871</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR159">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schedel</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kiyonaga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shindo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schutz</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Acute creatine ingestion in human: consequences on serum creatine and creatinine concentrations</article-title>
          <source>Life Sci</source>
          <year>1999</year>
          <volume>65</volume>
          <fpage>2463</fpage>
          <lpage>2470</lpage>
          <pub-id pub-id-type="pmid">10622230</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR160">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>17314</fpage>
          <lpage>17320</lpage>
          <pub-id pub-id-type="pmid">10748055</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR161">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Eder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khuchua</surname>
              <given-names>ZA</given-names>
            </name>
            <name>
              <surname>Strauss</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Divergent enzyme kinetics and structural properties of the two human mitochondrial creatine kinase isoenzymes</article-title>
          <source>Biol Chem</source>
          <year>2000</year>
          <volume>381</volume>
          <fpage>1063</fpage>
          <lpage>1070</lpage>
          <pub-id pub-id-type="pmid">11154064</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR162">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>48027</fpage>
          <lpage>48030</lpage>
          <pub-id pub-id-type="pmid">11602586</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR163">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Mockli</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Speer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Werner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase and creatine transporter in normal, wounded, and diseased skin</article-title>
          <source>J Invest Dermatol</source>
          <year>2002</year>
          <volume>118</volume>
          <fpage>416</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">11874479</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR164">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Gehring</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vernoux</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Marcillat</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Vial</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>C-terminal lysines determine phospholipid interaction of sarcomeric mitochondrial creatine kinase</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>24334</fpage>
          <lpage>24342</lpage>
          <pub-id pub-id-type="pmid">15044463</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR165">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial creatine kinase in human health and disease</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2006</year>
          <volume>1762</volume>
          <fpage>164</fpage>
          <lpage>180</lpage>
          <pub-id pub-id-type="pmid">16236486</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR166">
        <mixed-citation publication-type="other">Schlattner U, Tokarska-Schlattner M, Wallimann T (2006b) Molecular structure and function of mitochondrial creatine kinases. In: Vial C (ed), Uversky VN (series ed) Creatine kinase&#x2014;biochemistry, physiology, structure and function. Nova Science Publishers, New York, pp 123&#x2013;170</mixed-citation>
      </ref>
      <ref id="CR167">
        <mixed-citation publication-type="other">Schlattner U, Tokarska-Schlatner M, Wallimann T (2011) Metabolite channeling: creatine kinase microcompartments. In: Lennarz WJ and Lane DW (eds) Encyclopedia of biological chemistry. Elsevier (in press)</mixed-citation>
      </ref>
      <ref id="CR168">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schnyder</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cyrklaff</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Crystallization of mitochondrial creatine kinase on negatively charged lipid layers</article-title>
          <source>J Struct Biol</source>
          <year>1994</year>
          <volume>112</volume>
          <fpage>136</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">8060731</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR169">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schulze</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Creatine deficiency syndromes</article-title>
          <source>Mol Cell Biochem</source>
          <year>2003</year>
          <volume>244</volume>
          <fpage>143</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">12701824</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR170">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scopes</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>Studies with a reconstituted muscle glycolytic system. The rate and extent of creatine phosphorylation by anaerobic glycolysis</article-title>
          <source>Biochem J</source>
          <year>1973</year>
          <volume>134</volume>
          <fpage>197</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">4269207</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR171">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sestili</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Martinelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bravi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piccoli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Curci</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Battistelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Falcieri</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Agostini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gioacchini</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Stocchi</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity</article-title>
          <source>Free Radic Biol Med</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>837</fpage>
          <lpage>849</lpage>
          <pub-id pub-id-type="pmid">16520236</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR172">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheffy</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Shahani</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Grummer</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Nitrogen constituents of sow&#x2019;s milk as affected by ration and stage of lactation</article-title>
          <source>J Nutr</source>
          <year>1952</year>
          <volume>48</volume>
          <fpage>103</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">13000495</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR173">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shin</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Beynon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gadzala</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McMillen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bystrom</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
          <article-title>Hair bundles are specialized for ATP delivery via creatine kinase</article-title>
          <source>Neuron</source>
          <year>2007</year>
          <volume>53</volume>
          <fpage>371</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="pmid">17270734</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR174">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shulman</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Glycogen turnover forms lactate during exercise</article-title>
          <source>Exerc Sport Sci Rev</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>157</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="pmid">16239831</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR175">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sipila</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of arginine&#x2013;glycine amidinotransferase by ornithine. A possible mechanism for the muscular and chorioretinal atrophies in gyrate atrophy of the choroid and retina with hyperornithinemia</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1980</year>
          <volume>613</volume>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">7378422</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR176">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sistermans</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Kok</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ginsel</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry</article-title>
          <source>Cell Tissue Res</source>
          <year>1995</year>
          <volume>280</volume>
          <fpage>435</fpage>
          <lpage>446</lpage>
          <pub-id pub-id-type="pmid">7781040</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR177">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sistermans</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Klaassen</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Swarts</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Pont</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Co-localization and functional coupling of creatine kinase B and gastric H+/K(+)-ATPase on the apical membrane and the tubulovesicular system of parietal cells</article-title>
          <source>Biochem J</source>
          <year>1995</year>
          <volume>311</volume>
          <issue>Pt 2</issue>
          <fpage>445</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">7487880</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR178">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Neukomm</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Zanolla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine transporters: a reappraisal</article-title>
          <source>Mol Cell Biochem</source>
          <year>2004</year>
          <volume>256&#x2013;257</volume>
          <fpage>407</fpage>
          <lpage>424</lpage>
          <pub-id pub-id-type="pmid">14977199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR179">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Back</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Buerklen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Koretsky</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane</article-title>
          <source>Biochem J</source>
          <year>2005</year>
          <volume>385</volume>
          <fpage>445</fpage>
          <lpage>450</lpage>
          <pub-id pub-id-type="pmid">15294016</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR180">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spicer</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Schulte</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase in epithelium of the inner ear</article-title>
          <source>J Histochem Cytochem</source>
          <year>1992</year>
          <volume>40</volume>
          <fpage>185</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="pmid">1313059</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR181">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stachowiak</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Membrane-binding and lipid vesicle cross-linking kinetics of the mitochondrial creatine kinase octamer</article-title>
          <source>Biochemistry</source>
          <year>1996</year>
          <volume>35</volume>
          <fpage>15522</fpage>
          <lpage>15528</lpage>
          <pub-id pub-id-type="pmid">8952506</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR182">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stachowiak</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Oligomeric state and membrane binding behaviour of creatine kinase isoenzymes: implications for cellular function and mitochondrial structure</article-title>
          <source>Mol Cell Biochem</source>
          <year>1998</year>
          <volume>184</volume>
          <fpage>141</fpage>
          <lpage>151</lpage>
          <pub-id pub-id-type="pmid">9746318</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR183">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stadhouders</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial creatine kinase: a major constituent of pathological inclusions seen in mitochondrial myopathies</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>5089</fpage>
          <lpage>5093</lpage>
          <pub-id pub-id-type="pmid">8197190</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR184">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steeghs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Benders</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Haan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruitenbeek</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Perryman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pette</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bruckwilder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koudijs</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Veerkamp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies</article-title>
          <source>Cell</source>
          <year>1997</year>
          <volume>89</volume>
          <fpage>93</fpage>
          <lpage>103</lpage>
          <pub-id pub-id-type="pmid">9094718</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR185">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steeghs</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Haan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Verdoodt</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ruitenbeek</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Benders</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tullson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Terjung</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Pette</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cytoarchitectural and metabolic adaptations in muscles with mitochondrial and cytosolic creatine kinase deficiencies</article-title>
          <source>Mol Cell Biochem</source>
          <year>1998</year>
          <volume>184</volume>
          <fpage>183</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="pmid">9746321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR186">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Straumann</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wind</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Leuenberger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of N-linked glycosylation on the creatine transporter</article-title>
          <source>Biochem J</source>
          <year>2006</year>
          <volume>393</volume>
          <fpage>459</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">16167890</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR187">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ellenbroek</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Jost</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Structural and behavioural consequences of double deficiency for creatine kinases BCK and UbCKmit</article-title>
          <source>Behav Brain Res</source>
          <year>2005</year>
          <volume>157</volume>
          <fpage>219</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">15639173</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR188">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pluk</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Beckers</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bianco</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Mice lacking brain-type creatine kinase activity show defective thermoregulation</article-title>
          <source>Physiol Behav</source>
          <year>2009</year>
          <volume>97</volume>
          <fpage>76</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">19419668</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR189">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Streijger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Scheenen</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Luijtelaar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zee</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Complete brain-type creatine kinase deficiency in mice blocks seizure activity and affects intracellular calcium kinetics</article-title>
          <source>Epilepsia</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>79</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">19624717</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR190">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sullivan</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Mattson</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Scheff</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Dietary supplement creatine protects against traumatic brain injury</article-title>
          <source>Ann Neurol</source>
          <year>2000</year>
          <volume>48</volume>
          <fpage>723</fpage>
          <lpage>729</lpage>
          <pub-id pub-id-type="pmid">11079535</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR191">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tachikawa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hosoya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohtsuki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Terasaki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A novel relationship between creatine transport at the blood&#x2013;brain and blood&#x2013;retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis</article-title>
          <source>Subcell Biochem</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>83</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">18652073</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR192">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tagami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sakuma</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Matsumura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakano</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of altered myocardial high energy phosphate metabolism in patients on maintenance dialysis using phosphorus-31 magnetic resonance spectroscopy</article-title>
          <source>Invest Radiol</source>
          <year>1998</year>
          <volume>33</volume>
          <fpage>171</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">9525756</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR193">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Clinical use of creatine in neuromuscular and neurometabolic disorders</article-title>
          <source>Subcell Biochem</source>
          <year>2007</year>
          <volume>46</volume>
          <fpage>183</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">18652078</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR194">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarnopolsky</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Chorneyko</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lowther</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Johns</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Sandhu</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sikorska</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation</article-title>
          <source>Muscle Nerve</source>
          <year>2004</year>
          <volume>29</volume>
          <fpage>537</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">15052619</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR195">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity</article-title>
          <source>Mol Pharmacol</source>
          <year>2002</year>
          <volume>61</volume>
          <fpage>516</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="pmid">11854431</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR196">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meiler</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zandomeneghi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Do creatine and other guanidino compounds bind to phospholipid membranes? Studies with SPR and P-31-NMR-spectroscopy</article-title>
          <source>Biophys J</source>
          <year>2003</year>
          <volume>84</volume>
          <fpage>49A</fpage>
        </mixed-citation>
      </ref>
      <ref id="CR197">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Membrane protective effects of phosphocreatine</article-title>
          <source>Biophys J</source>
          <year>2005</year>
          <volume>88</volume>
          <fpage>418A</fpage>
        </mixed-citation>
      </ref>
      <ref id="CR198">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zaugg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>da Silva</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lucchinetti</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schaub</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply</article-title>
          <source>Am J Physiol Heart Circ Physiol</source>
          <year>2005</year>
          <volume>289</volume>
          <fpage>H37</fpage>
          <lpage>H47</lpage>
          <pub-id pub-id-type="pmid">15764680</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR199">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zaugg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zuppinger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics</article-title>
          <source>J Mol Cell Cardiol</source>
          <year>2006</year>
          <volume>41</volume>
          <fpage>389</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="pmid">16879835</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR200">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gerber</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Speer</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Reduced creatine-stimulated respiration in doxorubicin challenged mitochondria: particular sensitivity of the heart</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2007</year>
          <volume>1767</volume>
          <fpage>1276</fpage>
          <lpage>1284</lpage>
          <pub-id pub-id-type="pmid">17935690</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR201">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tombes</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Enzyme termini of a phosphocreatine shuttle. Purification and characterization of two creatine kinase isozymes from sea urchin sperm</article-title>
          <source>J Biol Chem</source>
          <year>1987</year>
          <volume>262</volume>
          <fpage>16011</fpage>
          <lpage>16019</lpage>
          <pub-id pub-id-type="pmid">3680241</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR202">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tombes</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Brokaw</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase-dependent energy transport in sea urchin spermatozoa. Flagellar wave attenuation and theoretical analysis of high energy phosphate diffusion</article-title>
          <source>Biophys J</source>
          <year>1987</year>
          <volume>52</volume>
          <fpage>75</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">2955815</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR203">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulijaszek</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Comparative energetics of primate fetal growth</article-title>
          <source>Am J Hum Biol</source>
          <year>2002</year>
          <volume>14</volume>
          <fpage>603</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="pmid">12203814</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR204">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valastro</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Dekundy</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Danysz</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Quack</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Oral creatine supplementation attenuates <sc>l</sc>-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats</article-title>
          <source>Behav Brain Res</source>
          <year>2009</year>
          <volume>197</volume>
          <fpage>90</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">18762218</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR205">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thillart</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Waarde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Erkelens</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Addink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lugtenburg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Fish muscle energy metabolism measured by in vivo 31P-NMR during anoxia and recovery</article-title>
          <source>Am J Physiol</source>
          <year>1989</year>
          <volume>256</volume>
          <fpage>R922</fpage>
          <lpage>R929</lpage>
          <pub-id pub-id-type="pmid">2705580</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR206">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Oerlemans</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ruitenbeek</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>ter Laak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity</article-title>
          <source>Cell</source>
          <year>1993</year>
          <volume>74</volume>
          <fpage>621</fpage>
          <lpage>631</lpage>
          <pub-id pub-id-type="pmid">8358791</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR207">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ruitenbeek</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Heerschap</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jap</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>ter Laak</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase (CK) in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in muscle CK expression</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>9091</fpage>
          <lpage>9095</lpage>
          <pub-id pub-id-type="pmid">8090775</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR208">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorsten</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Furter</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bijkerk</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The in vitro kinetics of mitochondrial and cytosolic creatine kinase determined by saturation transfer 31P-NMR</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1996</year>
          <volume>1274</volume>
          <fpage>59</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">8645695</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR209">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorsten</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Activation of sea-urchin sperm motility is accompanied by an increase in the creatine kinase exchange flux</article-title>
          <source>Biochem J</source>
          <year>1997</year>
          <volume>325</volume>
          <issue>Pt 2</issue>
          <fpage>411</fpage>
          <lpage>416</lpage>
          <pub-id pub-id-type="pmid">9230121</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR210">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leemputte</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vandenberghe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hespel</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Shortening of muscle relaxation time after creatine loading</article-title>
          <source>J Appl Physiol</source>
          <year>1999</year>
          <volume>86</volume>
          <fpage>840</fpage>
          <lpage>844</lpage>
          <pub-id pub-id-type="pmid">10066694</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR211">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waarde</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Thillart</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Erkelens</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Addink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lugtenburg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Functional coupling of glycolysis and phosphocreatine utilization in anoxic fish muscle. An in vivo 31P NMR study</article-title>
          <source>J Biol Chem</source>
          <year>1990</year>
          <volume>265</volume>
          <fpage>914</fpage>
          <lpage>923</lpage>
          <pub-id pub-id-type="pmid">2295625</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR212">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veksler</surname>
              <given-names>VI</given-names>
            </name>
            <name>
              <surname>Kuznetsov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Anflous</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mateo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Muscle creatine kinase-deficient mice. II. Cardiac and skeletal muscles exhibit tissue-specific adaptation of the mitochondrial function</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>19921</fpage>
          <lpage>19929</lpage>
          <pub-id pub-id-type="pmid">7650007</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR213">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vendelin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lemba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Analysis of functional coupling: mitochondrial creatine kinase and adenine nucleotide translocase</article-title>
          <source>Biophys J</source>
          <year>2004</year>
          <volume>87</volume>
          <fpage>696</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="pmid">15240503</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR214">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mekhfi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Vassort</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Role of creatine kinase in force development in chemically skinned rat cardiac muscle</article-title>
          <source>J Gen Physiol</source>
          <year>1987</year>
          <volume>89</volume>
          <fpage>815</fpage>
          <lpage>837</lpage>
          <pub-id pub-id-type="pmid">3496424</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR215">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kuznetsov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>d&#x2019;Albis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Deursen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Veksler</surname>
              <given-names>VI</given-names>
            </name>
          </person-group>
          <article-title>Muscle creatine kinase-deficient mice. I. Alterations in myofibrillar function</article-title>
          <source>J Biol Chem</source>
          <year>1995</year>
          <volume>270</volume>
          <fpage>19914</fpage>
          <lpage>19920</lpage>
          <pub-id pub-id-type="pmid">7650006</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR216">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ventura-Clapier</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kaasik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Veksler</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Structural and functional adaptations of striated muscles to CK deficiency</article-title>
          <source>Mol Cell Biochem</source>
          <year>2004</year>
          <volume>256&#x2013;257</volume>
          <fpage>29</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">14977168</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR217">
        <mixed-citation publication-type="other">Wallimann T (1975) Creatine kinase isoenzymes and myofibrillar structure. PhD Thesis Nr 5437, ETH Zurich</mixed-citation>
      </ref>
      <ref id="CR218">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Properties of arginine kinase from <italic>Drosophila melanogaster</italic></article-title>
          <source>Eur J Biochem</source>
          <year>1973</year>
          <volume>38</volume>
          <fpage>180</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="pmid">4359471</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR219">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Localization and function of M-line-bound creatine kinase. M-band model and creatine phosphate shuttle</article-title>
          <source>Cell Muscle Motil</source>
          <year>1985</year>
          <volume>6</volume>
          <fpage>239</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">3888375</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR220">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hemmer</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase in non-muscle tissues and cells</article-title>
          <source>Mol Cell Biochem</source>
          <year>1994</year>
          <volume>133&#x2013;134</volume>
          <fpage>193</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="pmid">7808454</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR221">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schlosser</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Function of M-line-bound creatine kinase as intramyofibrillar ATP regenerator at the receiving end of the phosphorylcreatine shuttle in muscle</article-title>
          <source>J Biol Chem</source>
          <year>1984</year>
          <volume>259</volume>
          <fpage>5238</fpage>
          <lpage>5246</lpage>
          <pub-id pub-id-type="pmid">6143755</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR222">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zurbriggen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wegmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Creatine kinase isoenzymes in spermatozoa</article-title>
          <source>J Muscle Res Cell Motil</source>
          <year>1986</year>
          <volume>7</volume>
          <fpage>25</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">3514665</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR223">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wegmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>High content of creatine kinase in chicken retina: compartmentalized localization of creatine kinase isoenzymes in photoreceptor cells</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1986</year>
          <volume>83</volume>
          <fpage>3816</fpage>
          <lpage>3819</lpage>
          <pub-id pub-id-type="pmid">3520556</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR224">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nicolay</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
          </person-group>
          <article-title>Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the &#x2018;phosphocreatine circuit&#x2019; for cellular energy homeostasis</article-title>
          <source>Biochem J</source>
          <year>1992</year>
          <volume>281</volume>
          <issue>Pt 1</issue>
          <fpage>21</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">1731757</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR225">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dolder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Eder</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hornemann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>O&#x2019;Gorman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ruck</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brdiczka</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology</article-title>
          <source>Biofactors</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>229</fpage>
          <lpage>234</lpage>
          <pub-id pub-id-type="pmid">9914824</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR226">
        <mixed-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tokarska-Schlattner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Neumann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Epand</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Epand</surname>
              <given-names>RF</given-names>
            </name>
            <name>
              <surname>Andres</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Hornemann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saks</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Agarkova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schlattner</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Saks</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>The phospho-creatine circuit: molecular and cellular physiology of creatine kinases, sensitivity to free radicals and enhancement by creatine supplementation</article-title>
          <source>Molecular systems bioenergetics: energy for life</source>
          <year>2007</year>
          <publisher-loc>Weinheim</publisher-loc>
          <publisher-name>Wiley</publisher-name>
          <fpage>195</fpage>
          <lpage>264</lpage>
        </mixed-citation>
      </ref>
      <ref id="CR227">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watanabe</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation</article-title>
          <source>Neurosci Res</source>
          <year>2002</year>
          <volume>42</volume>
          <fpage>279</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">11985880</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR228">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watchko</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Daood</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wieringa</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Koretsky</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <article-title>Myofibrillar or mitochondrial creatine kinase deficiency alone does not impair mouse diaphragm isotonic function</article-title>
          <source>J Appl Physiol</source>
          <year>2000</year>
          <volume>88</volume>
          <fpage>973</fpage>
          <lpage>980</lpage>
          <pub-id pub-id-type="pmid">10710393</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR229">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watt</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Garnham</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Snow</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Skeletal muscle total creatine content and creatine transporter gene expression in vegetarians prior to and following creatine supplementation</article-title>
          <source>Int J Sport Nutr Exerc Metab</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>517</fpage>
          <lpage>531</lpage>
          <pub-id pub-id-type="pmid">15673098</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR230">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wegmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zanolla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Differential expression and localization of brain-type and mitochondrial creatine kinase isoenzymes during development of the chicken retina: Mi-CK as a marker for differentiation of photoreceptor cells</article-title>
          <source>Differentiation</source>
          <year>1991</year>
          <volume>46</volume>
          <fpage>77</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">2065867</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR231">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wegmann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zanolla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eppenberger</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>In situ compartmentation of creatine kinase in intact sarcomeric muscle: the acto-myosin overlap zone as a molecular sieve</article-title>
          <source>J Muscle Res Cell Motil</source>
          <year>1992</year>
          <volume>13</volume>
          <fpage>420</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">1401038</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR232">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaddurah-Daouk</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Creatine and creatinine metabolism</article-title>
          <source>Physiol Rev</source>
          <year>2000</year>
          <volume>80</volume>
          <fpage>1107</fpage>
          <lpage>1213</lpage>
          <pub-id pub-id-type="pmid">10893433</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR233">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>112</volume>
          <fpage>243</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="pmid">12044443</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR234">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wyss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wallimann</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Creatine metabolism and the consequences of creatine depletion in muscle</article-title>
          <source>Mol Cell Biochem</source>
          <year>1994</year>
          <volume>133&#x2013;134</volume>
          <fpage>51</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">7808465</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR235">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Malmendal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Straadt</surname>
              <given-names>IK</given-names>
            </name>
            <name>
              <surname>Oksbjerg</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bertram</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Creatine-induced activation of antioxidative defence in myotube cultures revealed by explorative NMR-based metabonomics and proteomics</article-title>
          <source>J Int Soc Sports Nutr</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>9</fpage>
          <pub-id pub-id-type="pmid">20205771</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR236">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yquel</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Arsac</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Thiaudiere</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Canioni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Manier</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Effect of creatine supplementation on phosphocreatine resynthesis, inorganic phosphate accumulation and pH during intermittent maximal exercise</article-title>
          <source>J Sports Sci</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>427</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="pmid">12043832</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR237">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zemtsov</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Skin phosphocreatine</article-title>
          <source>Skin Res Technol</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>115</fpage>
          <lpage>118</lpage>
          <pub-id pub-id-type="pmid">17374051</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR238">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhivotovsky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Galluzzi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kepp</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Kroemer</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery</article-title>
          <source>Cell Death Differ</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>1419</fpage>
          <lpage>1425</lpage>
          <pub-id pub-id-type="pmid">19696789</pub-id>
        </mixed-citation>
      </ref>
      <ref id="CR239">
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziegenfuss</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Lowery</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Lemon</surname>
              <given-names>PWR</given-names>
            </name>
          </person-group>
          <article-title>Acute fluid volume changes in men during three days of creatine supplementation</article-title>
          <source>J Exerc Physiol</source>
          <year>1998</year>
          <volume>1</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
    <app-group>
      <app id="App1">
        <sec id="Sec31">
          <title>Appendix</title>
          <p>For a general update in the field, see the recently published books:<list list-type="bullet"><list-item><p>Saks VA (ed) (2007) Molecular systems bioenergetics: energy for life. Wiley&#x2013;VCH, Weinheim.</p></list-item><list-item><p>Salomons GS, Wyss M (eds) (2007) Creatine and creatine kinase in health and disease. Subcellular Biochemistry, vol 46. Springer, Dordrecht.</p></list-item><list-item><p>Vial C (ed), Uversky VN (series ed) (2006) Creatine kinase&#x2014;biochemistry, physiology, structure and function. Nova Science Publishers, New York.</p></list-item></list></p>
        </sec>
      </app>
    </app-group>
  </back>
</article>
